David Horrobin

Q: What Schools Are Affiliated With David Horrobin

David Horrobin is affiliated with the following schools: University of Rochester, Harvard University, Washington University in St. Louis, University of Oxford, Newcastle University

David Horrobin's AcademicInfluence.com Rankings

David Horrobin

Biology

#975

World Rank

#1690

Historical Rank

Physiology

#12

World Rank

#64

Historical Rank

biology Degrees

David Horrobin

Philosophy

#1254

World Rank

#2318

Historical Rank

Logic

#168

World Rank

#395

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

David Horrobin's Degrees

PhD Physiology University of Oxford

Why Is David Horrobin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David Frederick Horrobin was a British-Canadian entrepreneur, medical researcher, author and editor. He is best known as the founder of the biotechnology company Scotia Holdings and as a promoter of evening primrose oil as a medical treatment, Horrobin was founder and editor of the journals Medical Hypotheses and Prostaglandins, Leukotrienes and Essential Fatty Acids, the latter journal co-founded with his then graduate student Morris Karmazyn.

(See a Problem?)

David Horrobin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human Body Composition (1962) (788)
Adult lean body mass declines with age: some longitudinal observations. (1970) (676)
A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. (2002) (620)
Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients (1998) (605)
Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. (1998) (489)
Urinary creatinine excretion and lean body mass. (1976) (474)
Nutritional and medical importance of gamma-linolenic acid. (1992) (434)
The philosophical basis of peer review and the suppression of innovation. (1990) (424)
The membrane hypothesis of schizophrenia (1994) (325)
Lean body mass-body fat interrelationships in humans. (2009) (320)
Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. (1986) (314)
A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. (2002) (314)
The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia (1998) (286)
Commentary on breast-feeding and infant formulas, including proposed standards for formulas. (1976) (286)
Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. (1988) (281)
Total sodium, potassium and chloride in adult man. (1956) (266)
Lean body mass in obesity. (1983) (258)
Fish consumption and depression: the Northern Finland 1966 birth cohort study. (2004) (251)
Book Review: Human Body Composition: Growth, Aging, Nutrition, and Activity (1987) (249)
Fatty acid levels in the brains of schizophrenics and normal controls (1991) (247)
A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases (1994) (242)
Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. (1999) (238)
Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients (2003) (230)
Modern biomedical research: an internally self-consistent universe with little contact with medical reality? (2003) (226)
Age-related changes in synaptic function: analysis of the effect of dietary supplementation with ω-3 fatty acids (1999) (213)
Meta‐analysis of placebo‐controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response (1989) (196)
Selective killing of human cancer cells by polyunsaturated fatty acids. (1985) (193)
Fatty acid metabolism in health and disease: the role of delta-6-desaturase. (1993) (185)
Essential fatty acid metabolism and its modification in atopic eczema. (2000) (182)
The adult decline in lean body mass. (1976) (181)
Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. (1982) (179)
Omega-6 essential fatty acids : pathophysiology and roles in clinical medicine (1990) (176)
Estimation of Total Body Fat from Potassium-40 Content (1961) (175)
Longitudinal changes in adult fat-free mass: influence of body weight. (1999) (174)
Calcium metabolism, osteoporosis and essential fatty acids: a review. (1997) (173)
Deliberate overfeeding in women and men: energy cost and composition of the weight gain (1986) (168)
Effect of age on gastrointestinal absorption (Fe, Sr, Pb) in the rat. (1972) (167)
Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. (2003) (165)
Apoptotic Changes in the Aged Brain Are Triggered by Interleukin-1β-induced Activation of p38 and Reversed by Treatment with Eicosapentaenoic Acid* (2002) (156)
Effect of high doses of essential fatty acids on the postviral fatigue syndrome (1990) (151)
Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. (1995) (150)
Elevated levels of prostaglandin E2 and thromboxane B2 in depression. (1983) (146)
Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? (1987) (143)
Effects of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids (1998) (142)
The effect of anabolic steroids on lean body mass: the dose response curve. (1985) (141)
Body Fat Content Influences the Body Composition Response to Nutrition and Exercise (2000) (139)
Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro. (1987) (135)
Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. (1998) (132)
SCHIZOPHRENIA AS A PROSTAGLANDIN DEFICIENCY DISEASE (1977) (132)
Essential fatty acids in the plasma phospholipids of patients with atopic eczema (1984) (131)
Bromide space determination using anion-exchange chromatography for measurement of bromide. (1989) (130)
Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. (1992) (127)
Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. (1998) (127)
PROLACTIN AND THE IMMUNE RESPONSE (1974) (123)
Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. (1995) (120)
Ethyl-EPA in Huntington disease (2005) (119)
AGE AND SEX TRENDS IN LEAN BODY MASS CALCULATED FROM K40 MEASUREMENTS: WITH A NOTE ON THE THEORETICAL BASIS FOR THE PROCEDURE * (1963) (116)
A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia (1989) (114)
Iron absorption in the thalassemia syndromes and its inhibition by tea. (1979) (113)
Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. (1978) (113)
Estimation of total body sodium by isotopic dilution. I. Studies on young adults. (1951) (113)
LEAN BODY MASS AND FAT IN OBESE CHILDREN. (1964) (112)
The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism. (1983) (111)
TREATMENT OF ATOPIC ECZEMA WITH EVENING PRIMROSE OIL (1981) (111)
Thromboxane A2 in blood vessel walls and its physiological significance: relevance to thrombosis and hypertension. (1980) (110)
SCHIZOPHRENIA: RECONCILIATION OF THE DOPAMINE, PROSTAGLANDIN, AND OPIOID CONCEPTS AND THE ROLE OF THE PINEAL (1979) (107)
Loss of delta-6-desaturase activity as a key factor in aging. (1981) (107)
Neuroprotective Effect of Eicosapentaenoic Acid in Hippocampus of Rats Exposed to γ-Irradiation* (2002) (106)
Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects (1996) (105)
A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy (1998) (105)
Methyl xanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. (1977) (104)
New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. (1999) (104)
Cardiac arrhythmias associated with a liquid protein diet for the treatment of obesity. (1980) (103)
A biochemical basis for alcoholism and alcohol-induced damage including the fetal alcohol syndrome and cirrhosis: interference with essential fatty acid and prostaglandin metabolism. (1980) (103)
n-3 Essential fatty acids decrease weight gain in genetically obese mice (1986) (102)
The role of linoleic acid and its metabolites in the lowering of plasma cholesterol and the prevention of cardiovascular disease. (1987) (102)
Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1β administration Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.M300526-JLR200 (2004) (102)
MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment (2002) (102)
Prolactin and zinc effects on rat vascular reactivity: possible relationship to dihomo-gamma-linolenic acid and to prostaglandin synthesis. (1979) (100)
Estimation of Total Body Fat from Potassium-40 Content (1961) (100)
Regulation of the Expression of E-Cadherin on Human Cancer Cells by γ-Linolenic Acid (GLA) (1995) (98)
Indomethacin inhibits responses to all vasoconstrictors in the rat mesenteric vascular bed: restoration of responses by prostaglandin E2. (1976) (98)
Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats. (2008) (97)
Letter: Calcium accumulation by the human fetus. (1976) (96)
Methods for determining composition of the human body. With a note on the effect of diet on body composition. (1962) (96)
The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of I and 2 series prostaglandins: relevance to inflammation and immunity. (1980) (95)
Peer review of grant applications: a harbinger for mediocrity in clinical research? (1996) (95)
Schizophrenia as a membrane lipid disorder which is expressed throughout the body. (1996) (94)
Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. (1998) (94)
Ethyl-EPA in Alzheimer's disease--a pilot study. (2004) (94)
Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1β in rats (2004) (93)
Referees and research administrators: barriers to scientific research? (1974) (93)
Innovation in the pharmaceutical industry (2000) (93)
Something rotten at the core of science? (2001) (92)
Membrane fatty acids, niacin flushing and clinical parameters. (1996) (91)
Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. II. Effects of vitamin C. (1979) (90)
Energy expenditure under free-living conditions in normal-weight and overweight women. (1992) (90)
Possible role of prostaglandin E1 in the affective disorders and in alcoholism. (1980) (88)
The nutritional regulation of T lymphocyte function. (1979) (87)
Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia. (1995) (87)
Prostaglandins and schizophrenia: further discussion of the evidence (1978) (87)
Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. (1999) (87)
Most biological effects of zinc deficiency corrected by γ-linolenic acid (18: 3ω6) but not by linoleic acid (18: 2ω6) (1982) (86)
Hormonal response to overfeeding. (1989) (86)
Essential fatty acids in the plasma phospholipids of patients with atopic eczema. (1984) (83)
Schizophrenia: the illness that made us human. (1998) (83)
Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding. (2002) (82)
Effects of starvation in infancy (pyloric stenosis) on subsequent learning abilities. (1975) (82)
Age-related changes in LTP and antioxidant defenses are reversed by an α-lipoic acid-enriched diet (1999) (81)
The lateral cervical nucleus of the cat; an electrophysiological study. (1966) (81)
Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: an update. (2000) (80)
Changes of plasma lipids and long-chain n-3 and n-6 fatty acids in plasma, liver, heart and kidney phospholipids of rats fed variable levels of fish oil with or without cholesterol supplementation. (1986) (79)
The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1. (1980) (79)
Realism in drug discovery—could Cassandra be right? (2001) (78)
Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. (1987) (77)
Effects of body size on potassium-40 measurement in the whole body counter (tilt-chair technique). (1968) (77)
Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide‐induced dysfunction in rat hippocampus (2004) (77)
Fatty acids in plasma and red cell membranes in normal humans (1983) (77)
Essential Fatty Acids in the Management of Impaired Nerve Function in Diabetes (1997) (76)
Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders (1987) (76)
Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study. (1994) (76)
Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. (1994) (76)
Nutrition and growth. (1977) (75)
Essential fatty acids in plasma phospholipids in schizophrenics (1989) (75)
Interactions between zinc, essential fatty acids and prostaglandins: relevance to acrodermatitis enteropathica, total parenteral nutrition, the glucagonoma syndrome, diabetes, anorexia nervosa and sickle cell anaemia. (1980) (75)
The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. (2006) (75)
Genetic variant near cytosolic phospholipase A2 associated with schizophrenia (1996) (74)
Interactions between prostaglandins and calcium: the importance of bell-shaped dose-response curves. (1977) (73)
Techniques for Measuring Body Composition. (1962) (73)
Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation (1999) (72)
Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed. (2002) (72)
Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. (2002) (71)
CHLOROQUINE, QUININE, PROCAINE, QUINIDINE, TRICYCLIC ANTIDEPRESSANTS, AND METHYLXANTHINES AS PROSTAGLANDIN AGONISTS AND ANTAGONISTS (1976) (71)
Dietary Ethyl-eicosapentaenoic Acid but not Soybean Oil Reverses Central Interleukin-1-induced Changes in Behavior, Corticosterone and Immune Response in Rats (2004) (70)
Prolactin: Physiology and Clinical Significance (1973) (69)
Essential fatty acids, prostaglandins, and alcoholism: an overview. (1987) (68)
Effects of prolactin on the responses of rat aortic and arteriolar smooth-muscle preparations to noradrenaline and angiotensin. (1973) (68)
Is bioimpedance a good predictor of body-composition change? (1992) (68)
How do polyunsaturated fatty acids lower plasma cholesterol levels? (1983) (67)
Body composition changes during recovery from anorexia nervosa: comparison of two dietary regimes. (1984) (66)
Arm muscle plus bone area: anthropometry and CAT scan compared. (1988) (66)
Essential fatty acids in clinical dermatology. (1989) (66)
Modification of liver fatty acid metabolism in mice by n-3 and n-6 delta 6-desaturase substrates and products. (1991) (65)
A high protein, low calorie liquid diet in the treatment of very obese adolescents: long-term effect on lean body mass. (1983) (65)
Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. (1998) (64)
Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). (1995) (64)
Schizophrenia: The illness that made us human (1998) (64)
The role of essential fatty acids and prostaglandins in the premenstrual syndrome. (1983) (64)
Another source of error in the metabolic balance method. (2009) (64)
Long-term administration of antiepileptic drugs and the development of rickets. (1972) (63)
HUMAN GROWTH AFTER BIRTH (1974) (63)
Effects of Oral Supplementation with Evening Primrose Oil for Six Weeks on Plasma Essential Fatty Acids and Uremic Skin Symptoms in Hemodialysis Patients (1999) (62)
Arachidonic acid: a common link in the biology of schizophrenia? (1994) (62)
Loss of body nitrogen on fasting. (1979) (62)
Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists. (1976) (61)
γ-Linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome Δ6-desaturase activity (1991) (61)
Glycogen storage disease (1953) (60)
Eicosapentaenoic acid in treatment-resistant depression. (2002) (60)
Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. (1984) (60)
Interactions between n-3 and n-6 essential fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation. (1991) (59)
Stature and lean body mass. (1974) (59)
Changes of vascular reactivity induced by low vasopressin concentrations: interactions with cortisol and lithium and possible involvement of prostaglandins. (1978) (59)
The pineal and regulation of fibrosis: pinealectomy as a model of primary biliary cirrhosis: roles of melatonin and prostaglandins in fibrosis and regulation of T lymphocytes. (1979) (59)
Body Composition in Adolescence (1986) (58)
Plasma fatty acid levels in patients with acquired immune deficiency syndrome and in controls. (1989) (57)
Exercise and body composition. (1991) (56)
Prostaglandins and thromboxane outflow from the perfused mesenteric vascular bed in spontaneously hypertensive rats. (1985) (56)
Effects of prostaglandins on baseline pressure and responses to noradrenaline in a perfused rat mesenteric artery preparation. PGE1 as an antagonist of PGE2. (1977) (56)
Patients with primary Sjögren's syndrome treated for two months with evening primrose oil. (1986) (56)
Estimation of total body sodium by isotopic dilution. II. Studies on infants and children: an example of a constant differential growth ratio. (1951) (56)
Fluoride Supplementation: Revised Dosage Schedule: Committee on Nutrition (1979) (56)
Resting metabolic rates of obese women after rapid weight loss. (1984) (56)
Are large clinical trials in rapidly lethal diseases usually unethical? (2003) (56)
Aspirin, indomethacin, catecholamine and prostaglandin interactions on rat arterioles and rabbit hearts (1974) (55)
Estimation of total body fat from potassium-40 content. (2009) (55)
Skinfold thickness and body fat in children. (1970) (55)
Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease? (1995) (54)
Changes in dietary fatty acids alter phospholipid fatty acid composition in selected regions of rat brain (1998) (54)
Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease. (1997) (53)
Essential Fatty Acids in Tissue Phospholipids and Triglycerides of the Zinc-Deficient Rat (1984) (53)
Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression. (2004) (53)
A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2. (1980) (53)
Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan (1991) (53)
Exercise and lean weight: the influence of body weight. (2009) (52)
Relation of Lean Body Mass to Height in Children and Adolescents (1972) (52)
Effect of cortisol, prolactin and ADH on the amniotic membrane (1975) (51)
Vascular actions of furosemide and bumetanide on the rat superior mesenteric vascular bed: interactions with prolactin and prostaglandins. (1976) (50)
Cellular basis of prolactin action: involvement of cyclic nucleotides, polyamines, prostaglandins, steroids, thyroid hormones, Na/K ATPases and calcium: relevance to breast cancer and the menstrual cycle. (1979) (50)
Ventricular dilation on CAT scans of patients with anorexia nervosa. (1986) (50)
ROLE OF PINEAL GLAND IN ÆTIOLOGY AND TREATMENT OF BREAST CANCER (1978) (49)
Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients. (1998) (49)
Levels of essential and other fatty acids in plasma and red cell phospholipids from normal controls and patients with atopic eczema. (1991) (48)
A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa. (2004) (48)
Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A‐independent transacylase (2001) (47)
The Madness of Adam and Eve: How Schizophrenia Shaped Humanity (2002) (47)
Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. (1989) (47)
Weight loss during fasting: implications for the obese. (1970) (47)
The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. (1988) (46)
Gammalinolenic acid treatment of fatigue associated with primary Sjögren's syndrome (2002) (46)
Lipid metabolism, human evolution and schizophrenia. (1999) (45)
Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. (1994) (45)
Sjogren's syndrome and the sicca syndrome: The role of prostaglandin El deficiency. Treatment with essential fatty acids and vitamin C (1980) (45)
Further observations on post-tracheotomy, mediastinal emphysema, and pneumothorax. (1947) (45)
Gamma linolenic acid regulates expression of maspin and the motility of cancer cells. (1997) (45)
Body composition in adolescence. (1981) (45)
IMPAIRED CALCIUM HOMEOSTASIS IN THE INFANTILE HYPERCALCEMIC SYNDROME (1972) (45)
A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system. (1981) (44)
Changes in human plasma essential fatty acid levels as a result of administration of linoleic acid and gamma-linolenic acid. (1988) (44)
Dipyridamole: a possible potent inhibitor of thromboxane A2 synthetase in vascular smooth muscle. (1977) (44)
Amelioration of both early and late radiation-induced damage to pig skin by essential fatty acids. (1994) (44)
Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action. (1977) (43)
Effective clinical innovation: an ethical imperative (2002) (43)
The febrile convulsion in shigellosis. (1958) (42)
The regulation of prostaglandin E1 formation: a candidate for one of the fundamental mechanisms involved in the actions of vitamin C. (1979) (42)
Peer review: A philosophically faulty concept which is proving disastrous for science (1982) (42)
The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism. (1992) (42)
The relationship between concentrations of prostaglandin A1, E1, E2 and E2alpha and rates of cell proliferation. (1979) (42)
The modulation of radiation-induced damage to pig skin by essential fatty acids. (1993) (41)
Influence of Physical Activity (1987) (41)
Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndrome. (1984) (41)
The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells. (1998) (40)
Increased levels of cytosolic phospholipase A2 in dyslexics. (2000) (40)
Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis. (1978) (40)
Joint FAO/WHO ad hoc Expert Committee, Energy and Protein Requirements, WHO Technical Report Series 522. (1974) (40)
Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration. (2004) (39)
Tin and fatty acids in dementia. (1991) (39)
Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism. (1989) (39)
Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin. (1980) (39)
omega-3 Fatty acid for schizophrenia. (2003) (38)
Diagnosis and management of severe infections in infants and children: A review of experiences since the introduction of sulfonamide therapy (1946) (38)
Plasma essential fatty acids in pure and mixed race American Indians on and off a diet exceptionally rich in salmon. (1985) (38)
Accumulation of Linoleic and γ-Linolenic Acids in Tissue Lipids of Pyridoxine-Deficient Rats (1984) (38)
Effect of hyaluronidase on the subcutaneous absorption of electrolytes in humans. (1950) (38)
Techniques for Estimating Body Composition (1987) (37)
Effect of prostacyclin on perfusion pressure, electrical activity, rate and force of contraction in isolated rat and rabbit hearts. (1978) (37)
Letter: Aspirin and arteriolar responses to noradrenaline. (1974) (37)
The companionship of lean and fat. (1993) (37)
Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. (1991) (37)
Silver nitrate and the eyes of the newborn. Credé's contribution to preventive medicine. (1971) (37)
Interrelationship between dietary protein, cholesterol and n-6 polyunsaturated fatty acid metabolism. (1993) (37)
The abdomen: hip ratio normative data and observations on selected patients. (1990) (36)
ALCOHOL CONSUMPTION AND CORONARY HEART-DISEASE (1979) (36)
Tissue phospholipid fatty acid composition in the diabetic rat (1984) (36)
Role of zinc in linoleic acid desaturation and prostaglandin synthesis. (1981) (35)
Essential fatty acids and cardiovascular disease: the Edinburgh Artery Study (1999) (35)
Osteoporosis: a "new morbidity" for dieting female adolescents? (1990) (35)
Lipid peroxidation in human breast cancer cells in response to gamma-linolenic acid and iron. (1992) (35)
In vitro hydrolysis of natural and synthetic γ-linolenic acid-containing triacylglycerols by pancreatic lipase (1995) (34)
Actions of the tricyclic antidepressant clomipramine on responses to pressor agents. Interactions with prostaglandin E2. (1977) (34)
Staphylococal infection of operation wounds with special reference to topical antibiotic prophylaxis. (1961) (34)
Stereospecific analysis of the major triacylglycerol species containing γ-linolenic acid in evening primrose oil and borage oil (1995) (34)
Aspects of Synthesis and Order in Growth (1956) (34)
Schizophrenia: a biochemical disorder? (1980) (34)
Lean body mass in twins. (1995) (34)
Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: the effects of glucose and insulin. (1986) (34)
Prevention of migraine by reducing prolactin levels. (1973) (33)
Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems. (2002) (33)
Is the main problem in free radical damage caused by radiation, oxygen and other toxins the loss of membrane essential fatty acids rather than the accumulation of toxic materials? (1991) (33)
Effect of Different Dietary Proteins on Plasma and Liver Fatty Acid Compositions in Growing Rats (1986) (33)
Body composition as affected by physical activity and nutrition. (1985) (32)
Mechanism of lipid peroxidation in cancer cells in response to gamma-linolenic acid (GLA) analyzed by GC-MS(I): Conjugated dienes with peroxyl (or hydroperoxyl) groups and cell-killing effects. (1993) (32)
Physiological cortisol levels block the inhibition of vascular reactivity produced by prolactin. (1976) (32)
Essential Fatty Acids in Alzheimer's Disease a (1991) (31)
The possible effect of diazepam on cancer development and growth. (1981) (31)
Influence of Nutrition (1987) (31)
Schizophrenia: the role of abnormal essential fatty acid and prostaglandin metabolism. (1983) (31)
New Method for the Estimation of Lean Body Mass in Infants (EMME Instrument): Validation in Nonhuman Models (1984) (30)
Actions of Prolactin and Frusemide on Heart Rate and Rhythm (1974) (30)
Sex Differences in n-3 and n-6 Fatty Acid Metabolism in EFA-Depleted Rats (1987) (30)
Water-losing action of antidiuretic hormone in the presence of excess cortisol: restoration of normal action by prolactin or by oxytocin. (1973) (30)
A Note on the Mathematics of “Catch-up” Growth (1974) (30)
Thromboxane A2 as a possible natural ligand for benzodiazepine receptors (1978) (30)
Quinacrine is a prostaglandin antagonist. (1977) (30)
Abnormalities of thymus growth in dystrophic mice (1976) (29)
Erythrocyte Protoporphyrin Levels in Patients with Friedreich's and other Ataxias (1979) (29)
Roles of prostaglandins suggested by the prostaglandin agonist/antagonist actions of local anaesthetic, anti-arrhythmic, anti-malarial, tricyclic anti-depressant and methyl xanthine compounds. Effects on membranes and on nucleic acid function. (1977) (29)
Parenteral Linoleic and γ-Linolenic Acids Ameliorate the Gross Effects of Zinc Deficiency (1980) (29)
Omega-6 and omega-3 essential fatty acids in atherosclerosis. (1993) (29)
Prolactin as a regulator of fluid and electrolyte metabolism in mammals. (1980) (29)
γ-Linolenic Acid Supplementation Can Affect Cancer Cell Proliferation via Modification of Fatty Acid Composition (1996) (28)
Airblock in the newborn infant. (1947) (28)
Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil. (1979) (28)
MRI changes in multiple sclerosis following treatment with lofepramine and l-phenylalanine (2001) (28)
Prolactin and Mental Illness (1974) (28)
Do obese individuals gain weight more easily than nonobese individuals? (1990) (28)
Contrasting effects of low or high copper intake on rat tissue lipid essential fatty acid composition. (1985) (28)
Fatty acid analysis of blood from violent offenders (1994) (28)
Food, Micronutrients, and Psychiatry (2002) (28)
Antidromic and synaptic responses in the cat's gracile nucleus to cerebellar stimulation (1967) (28)
The effects of dietary cholesterol on blood and liver polyunsaturated fatty acids and on plasma cholesterol in rats fed various types of fatty acid diet (1984) (28)
Management of tetanus; report of fifteen consecutive cases with recovery. (1955) (27)
Dantrolene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2. (1978) (27)
The influence of dietary manipulation with n−3 and n−6 fatty acids on liver and plasma phospholipid fatty acids in rats (1986) (27)
The effects of hydrogenated coconut oil, safflower oil, and evening primrose oil on development of hypertension and sodium handling in spontaneously hypertensive rats. (1985) (27)
The Effect of Chemical Hepatocarcinogenesis on Liver Phospholipid Composition in Rats Fed N-6 and N-3 Fatty Acid-Supplemented Diets (1992) (27)
Comparison of the grignard deacylation TLC and HPLC methods and high resolution 13C-NMR for the sn-2 positional analysis of triacylglycerols containing gamma-linolenic acid. (1996) (27)
Calculous disease of the vermiform appendix. (1966) (27)
Influence of agents which modulate thromboxane A2 synthesis or action on R3230AC mammary carcinoma. (1978) (27)
Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia (1991) (27)
Effects of low magnesium diet on the vascular prostaglandin and fatty acid metabolism in rats. (1988) (27)
Effect of acute hypernatremia, hyponatremia, and acidosis on bone sodium. (1965) (26)
Energy intake and body weight: a reexamination of two "classic" studies. (1984) (26)
Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20 degrees C proceeds faster in patients with schizophrenia when compared with healthy controls. (2003) (26)
Beyond conflict of interest. Non-financial conflicts of interest are more serious than financial conflicts. (1999) (26)
Alteration of tissue zinc distribution and biochemical analysis of serum following pinealectomy in the rat. (1979) (26)
Post-viral fatigue syndrome, viral infections in atopic eczema, and essential fatty acids. (1990) (26)
Human Energetics in Biological Anthropology (1996) (26)
Effect of different ratios of dietary N-6 and N-3 fatty acids on fatty acid composition, prostaglandin formation and platelet aggregation in the rat. (1987) (26)
Diet and exercise in obese subjects: self-report versus controlled measurements. (2009) (25)
A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E). (2002) (25)
Essential fatty acid metabolism in cultured rat cardiomyocytes in response to either N-6 or N-3 fatty acid supplementation. (1995) (25)
Body composition and the energy cost of weight gain. (1982) (25)
Response of tissue phospholipid fatty acid composition to dietary (n-6) and replacement with marine (n-3) and saturated fatty acids in the rat (1986) (25)
Perspectives on body composition. (2002) (24)
Relation of Age to Radiomagnesium Exchange in Bone.∗ (1960) (24)
Diet and breast cancer: the possible connection with sugar consumption. (1983) (24)
Low prostaglandin concentrations cause cardiac rhythm disturbances. Effect reversed by low levels of copper or chloroquine. (1978) (24)
Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933. (1996) (24)
Megavitamin Therapy for Childhood Psychoses and Learning Disabilities (1976) (24)
Prostaglandins E1, E2 and I2: evidence for three distinct actions in vascular smooth muscle. (1978) (24)
The effect of maternal supplementation with linoleic and gamma-linolenic acids on the fat composition and content of human milk: a placebo-controlled trial. (1991) (23)
The importance of linoleic acid metabolites in cancer metastasis and in the synthesis and actions of 13-HODE. (1997) (23)
Separation and quantification of the triacylglycerols in evening primrose and borage oils by reversed-phase high-performance liquid chromatography (1995) (23)
SOME EFFECTS OF LONG-TERM PROGESTERONE TREATMENT IN RABBITS AND THEIR RELEVANCE TO PRE-ECLAMPSIA (1968) (23)
Treatment of Severe and Moderately Severe Atopic Dermatitis with Evening Primrose Oil (Epogam): a Multi-centre Study (1991) (23)
Snakes and Other Reptiles (1971) (23)
Chylothorax in infancy (1944) (23)
Effect of ethanol on liver triglycerides and fatty acid composition in the golden Syrian hamster. (1985) (23)
Essential fatty acid status in cell membranes and plasma of patients with primary Sjogren's syndrome. Correlations to clinical and immunologic variables using a new model for classification and assessment of disease manifestations. (1998) (22)
CORRELATION OF POTASSIUM‐40 DATA WITH ANTHROPOMETRIC MEASUREMENTS * (1963) (22)
An outbreak of Q fever in East Kent. (1951) (22)
Changes in total body chloride during growth. (1956) (22)
Letter: Prolactin and the immune response. (1974) (22)
Glittering prizes for research support (1986) (22)
(Biochim. Biophys. Acta, 1082:319-327)Modification of liver fatty acid metabolism in mice by n-3 and n-6 Δ6 desaturase substrates and products (1991) (22)
Cholesterol metabolism and violence: a study of individuals convicted of violent crimes. (1993) (22)
Ideas in biomedical science: reasons for the foundation of Medical Hypotheses. (2004) (22)
Release of Fatty Acids by Perfused Vascular Tissue in Normotensive and Hypertensive Rats (1988) (22)
Effects of essential fatty acids on prostaglandin biosynthesis. (1984) (22)
gamma-Linolenic acid blocks cell cycle progression by regulating phosphorylation of p27kip1 and p57kip2 and their interactions with other cycle regulators in cancer cells. (1998) (21)
Rapid improvement of severe anorexia nervosa during treatment with ethyl-eicosapentaenoate and micronutrients (2004) (21)
Salicylate intoxication in the infant and young child; a report of 13 cases. (1947) (21)
Essential fatty acids in plasma, red blood cells and liver phospholipids in common laboratory animals as compared to humans (1984) (21)
Prostaglandins : physiology, pharmacology & clinical significance (1978) (21)
The effects of evening primrose oil, safflower oil and paraffin on plasma fatty acid levels in humans: choice of an appropriate placebo for clinical studies on primrose oil. (1991) (21)
Free radicals as possible mediators of the actions of interferon. (1986) (21)
Abnormal essential fatty acid composition of tissue lipids in genetically diabetic mice is partially corrected by dietary linoleic and γ-linolenic acids (1985) (21)
Special Diets for Infants With Inborn Errors of Amino Acid Metabolism (1976) (21)
Medical physiology and biochemistry (1968) (20)
422 IS HUMAN MILK THE BEST FOOD FOR LOW BIRTH WEIGHT BABIES? (1978) (20)
Thromboxane A2: a key regulator of prostaglandin biosynthesis and of interactions between prostaglandins, calcium and cyclic nucleotides. (1978) (20)
Vitamin E blocks the cytotoxic effect of gamma-linolenic acid when administered as late as the time of onset of cell death--insight into the mechanism of fatty acid induced cytotoxicity. (1996) (20)
Copper inhibits pressor responses to noradrenaline but not potassium. Interactions with prostaglandins E1, E2, and I2 and penicillamine. (1979) (20)
Body size and composition of perimenarchal girls. (1992) (20)
COMMITTEEON NUTRITION Composition of Milks (1960) (20)
Chemical growth in man. (1952) (20)
(IRCS Med. Sci., 13:684-687)Minerals, trace elements, and vitamins interact with essential fatty acids and prostaglandins to prevent hypertension, thrombosis, hypercholesterolemia and atherosclerosis and their attendant complications (1985) (20)
PROLACTIN AND PROSTAGLANDIN SYNTHESIS (1974) (19)
The influence of dietary marine oil (Polepa) and evening primrose oil (Efamol) on prostaglandin production by the rat mesenteric vasculature. (1987) (19)
MIND AND CANCER (1979) (19)
PROSTAGLANDINS AND SCHIZOPHRENIA (1980) (19)
American Academy of Pediatrics Committee Statement. The ten-state nutrition survey: a pediatric perspective. (1973) (19)
Effect of maternal dietary fats with variable n−3/n−6 ratios on tissue fatty acid composition in suckling mice (1992) (19)
The effect of gamma-linolenic acid on plasma and membrane lipids and renal prostaglandin synthesis in older subjects. (2002) (19)
Essential‐fatty‐acid metabolites in plasma phospholipids in patients with ichthyosis vulgaris, acne vulgaris and psoriasis (1990) (19)
Chloroquine enhances Epstein–Barr virus expression (1978) (19)
Body composition: overview. (1999) (18)
Essential fatty acids in the liver and adipose tissue of genetically obese mice: effect of supplemental linoleic and γ-linolenic acids (1985) (18)
Potentiation of pressor effects of noradrenaline and potassium ions in the rat mesenteric arteries by physiological concentrations of angiotensin II: effects of prostaglandin E2 and cortisol. (1977) (18)
Bioelectrical impedance and body composition: present status and future direction. (1994) (18)
Muscle weakness in infants with rickets: distribution, course, and recovery. (1986) (18)
Neurologic complications of systemic disease. (1954) (18)
The Kidneys and Urinary Tract (1973) (18)
Medical Uses Of Essential Fatty Acids (EFAs) (1993) (18)
Prostaglandins can prevent the binding of chloroquine to calf thymus DNA. (1976) (18)
Long-term ethanol consumption in the hamster: effects on tissue lipids, fatty acids and erythrocyte hemolysis. (1987) (17)
Fatty acid composition of serum phospholipids in an elderly institutionalized Japanese population. (1991) (17)
Effect of dietary depletion and repletion of linoleic acid on renal fatty acid composition and urinary prostaglandin excretion. (1984) (17)
Determination of sodium24 space in infants, children, and adults. (1951) (17)
The Northern Desert (1971) (17)
BACK TO BASICS: Fluids and Electrolytes—Clinical Aspects (1996) (17)
Essential Fatty Acids in Clinical Medicine (1983) (17)
Should Milk Drinking by Children Be Discouraged (1974) (17)
Magnesium deficiency in the rat increases tissue levels of docosahexaenoic acid. (1985) (17)
Regulation of Cytoplasmic Calcium: Interactions between Prostaglandins, Prostacyclin, Thromboxane A2, Zinc, Copper and Taurine (1978) (17)
The vascular response to zinc varies seasonally: effect of pinealectomy and melatonin. (1980) (17)
PROSTAGLANDINS AND SCHIZOPHRENIA (1979) (17)
Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation (2001) (17)
Expression of catenins in human cancer cells and its regulation by n-6 polyunsaturated fatty acids. (1995) (17)
DIPYRIDAMOLE AND PLATELET AGGREGATION (1978) (17)
Adenosine as a natural prostaglandin antagonist in vascular smooth muscle. (1977) (16)
(Nutrition, 04:337-341)Clinical significance of essential fatty acids (1988) (16)
Randomized Controlled Trial of Antioxidants in Intermittent Claudication (1997) (16)
Phospholipases: in search of a genetic base of schizophrenia. (1996) (16)
RAYNAUD'S PHENOMENON, HISTAMINE, AND PROSTAGLANDINS (1983) (16)
Influence of Hormones (1987) (16)
Growth of the lean body mass in man. (1972) (16)
Protective effect of gamma-linolenic acid on aspirin-induced gastric hemorrhage in rats. (1987) (16)
INFANTILE SCURVY AND NUTRITIONAL RICKETS IN THE UNITED STATES (1962) (16)
Abnormalities in dihomo-gamma-linolenic acid release in the pathogenesis of hypertension. (1993) (16)
Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids (1997) (16)
The Development of Man (1971) (15)
Estimation of total body chloride in man by radiobromide dilution. (1956) (15)
Present knowledge of vitamin D. (2009) (15)
Chemical growth in infancy and childhood. (1952) (15)
Vitamin E treatment of tardive dyskinesia. (1993) (15)
CHLORPROPAMIDE/ALCOHOL FLUSHING AND PROSTAGLANDINS (1980) (15)
The effects of gamma-linolenic acid on breast pain and diabetic neuropathy: possible non-eicosanoid mechanisms. (1993) (15)
Effect of dietary cholesterol and polyunsaturated fats on plasma and liver lipids in guinea pigs. (1987) (15)
Disorders of Fluid and Electrolyte Balance (1973) (15)
The effects of gamma-linolenic acid on human breast cancer cell killing, lipid peroxidation and the production of Schiff-reactive materials (1992) (15)
Ascorbic acid and prostaglandin synthesis. (1996) (15)
GROWTH OF THE LEAN BODY MASS DURING CHILDHOOD AND ADOLESCENCE. (1964) (15)
DIABETIC RETINOPATHY AND PROLACTIN (1974) (15)
Cytotoxicity and genotoxicity of lipid-oxidation products. Discussion (1993) (15)
Cortisol in physiological concentrations acts within minutes to modify effects of prolactin and growth hormone on prostaglandin secretion: importance of effect in modulating cellular responses to calcium and cyclic nucleotides. (1976) (15)
Mechanisms of the selective cytotoxic actions of certain essential fatty acids. (1997) (15)
DOPAMINE ENHANCES THE ACTION OF PROLACTIN ON RAT BLOOD VESSELS. DOPAMINE EFFECTS ON PLASMA PROLACTIN. IMPLICATIONS FOR (1977) (15)
Fetal growth and body composition: implications for the premature infant. (1983) (15)
Effects of dietary linoleic acid on growth and liver phospholipid fatty acid composition in intact and gonadectomized rats. (1990) (15)
Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid. (1996) (14)
Studies on sodium in bone. (1960) (14)
PROLACTIN AND MYOCARDIAL INFARCTION (1973) (14)
Effects of Lithium on Essential Fatty Acid and Prostaglandin Metabolism (1990) (14)
THYMIC CHANGES IN MUSCULAR DYSTROPHY AND EVIDENCE FOR AN ABNORMALITY RELATED TO PROSTAGLANDIN SYNTHESIS OR ACTION * (1979) (14)
Inhibition of neutrophil respiratory burst and cytokine priming by γ‐linolenic acid (1996) (14)
Type IV cPLA2 in red blood cells: Evidence for differences between two subgroups on dyslexic-type adults and controls (2000) (14)
Evening primrose oil and atopic eczema (1990) (14)
Parenteral administration of ammonium chloride for alkalosis of congenital hypertrophic pyloric stenosis; a preliminary report. (1946) (14)
Composition of milk produced by a mother with galactosemia. (1988) (14)
Peer review of statistics in medical research [2] (multiple letters) (2002) (14)
Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systemic sclerosis and rheumatoid arthritis. (1986) (14)
Treatment of the Sicca syndrome and Sjogren's syndrome with E.F.A., pyridoxine and vitamin C. (1981) (14)
Medical hubris: A reply to Ivan Illich (1970) (14)
The Membrane Phospholipid Concept of Schizophrenia (1999) (14)
Intestinal lymphangiectasia. Metabolic studies. (1969) (14)
Concentration-dependent effect of iron on gamma-linolenic acid toxicity in ZR-75-1 human breast tumor cells in culture. (1993) (13)
A comparison of chronologic age and gynecologic age as indices of biologic maturity. (1986) (13)
The possible roles of prostaglandin E1 and of essential fatty acids in mania, depression and alcoholism. (1981) (13)
Calcium Accumulation by the Human Fetus (1976) (13)
Prostaglandin A2 at low rates of infusion restores the antidiuretic effect of vasopressin in lithium-treated rats. (1977) (13)
Some adventures in body composition, with special reference to nutrition (2003) (13)
Seasonal and sexual variations in the responsiveness of rabbit hearts to prolactin. (1975) (13)
Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. I. Effects of ethanol. (1979) (13)
Letter: Plasma prolactin: effect of posture in hypertensive patients. (1975) (13)
Fatty Acid Distribution in Plasma Phospholipids in Normal Individuals from Different Geographical Locations (1991) (13)
Effects of propranolol on the responses of the rat stomach strip to prostaglandin E2. (1977) (13)
Commentary on the workshop statement: are we really sure that arachidonic acid and linoleic acid are bad things? (2000) (13)
Polyunsaturated fatty acids and colchicine in multiple sclerosis. (1979) (13)
Energy need for weight maintenance in human beings: effect of body size and composition. (1989) (13)
Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta 6-desaturase activity. (1991) (13)
The possible role of prolactin in pre-eclampsia. (1975) (13)
(Int. J. Cardiol., 17:241-255)The role of linoleic acid and its metabolites in the lowering of plasma cholesterol and the prevention of cardiovascular disease (1987) (13)
606 Clozapine: Elevation of membrane unsaturated lipid levels as a new mechanism of action (1997) (13)
Pneumothorax in the newborn infant (1943) (12)
Effect of salt-loading and spontaneous hypertension on in vitro metabolism of [1-14C]linoleic and [2-14C]dihomo-gamma-linolenic acids. (1993) (12)
Fatty Acids, Phospholipids, and Schizophrenia (1997) (12)
Comparison of the metabolism of α-linolenic acid and its Δ6 desaturation product, stearidonic acid, in cultured NIH-3T3 cells (1993) (12)
A distinctive obesity: body composition provides the clue. (1997) (12)
The relationships between cyclic AMP, calcium and prostaglandins as second messengers. (1977) (12)
Evening primrose oil in atopic eczema (1990) (12)
22 AGGRESSIVE BEHAVIORS IN YOUNG MOTHERS: MARKERS OF FUTURE MORBIDITY? (1981) (12)
The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism. (2003) (12)
Errors in potassium balance. (1981) (12)
Effects of dietary saturated, N-6 and N-3 polyunsaturated fats on blood pressure and prostaglandins outflow from perfused mesenteric vascular bed in rats. (1985) (12)
Effect of age on radiosodium exchange in bone (rat). (1957) (12)
Most biological effects of zinc deficiency corrected by gamma-linolenic acid (18: 3 omega 6) but not by linoleic acid (18: 2 omega 6). (1982) (12)
Hypothesis: prostaglandins and migraine. (1977) (12)
Body Composition in Infancy, Childhood, and Adolescence (1987) (12)
Effect of Dietary α- and -γ-Linolenic Acid on Tissue Fatty Acids in Guinea Pigs (1985) (12)
Metabolism of linoleic and α-linolenic acids in cultured cardiomyocytes: Effect of different N-6 and N-3 fatty acid supplementation (1996) (12)
INTERFERON FEVER (1977) (12)
Gamma linolenic acid inhibits tyrosine phosphorylation of focal adhesion kinase and paxillin and tumour cell matrix interaction. (1996) (11)
Changes in coronary vascular resistance associated with prolonged hypoxia in isolated rat hearts: a possible role of prostaglandins. (1979) (11)
Ideas in biomedical science: reasons for the foundation of Medical Hypotheses. (1976) (11)
Some remarks on bone mineralization. (1988) (11)
Staphylococcal pneumonia and empyema. (1957) (11)
Abnormal essential fatty acid metabolism in Darier's disease. (1990) (11)
The roles of prostaglandins and calcium accumulation in muscular dystrophy. (1977) (11)
Regulation of blood glucose (1971) (11)
Body surface as a basis for dosage. (1959) (11)
Intracellular free Fatty-Acid release and lipid-peroxidation in cultured human breast-cancer cells in response to gamma-linolenic Acid with iron (gla + fe). (1992) (11)
Bone sodium as a function of serum sodium in rats. (1965) (11)
Glycogen storage disease; report of a case with abnormal glycogen structure in liver and skeletal muscle. (1953) (11)
Children and food--order amid chaos. (1991) (11)
Sjogren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C. (1980) (11)
Corrected bromide space. (1984) (11)
ASPIRIN AND ARTERIOLAR RESPONSES TO NORADRENALINE (1974) (11)
Dietary manipulation of ethanol preference in the Syrian Golden hamster (1986) (11)
Accumulation of linoleic and gamma-linolenic acids in tissue lipids of pyridoxine-deficient rats. (1984) (11)
Type IV cPLA2 in red blood cells: A preliminary clinical evaluation of its use as a marker for schizophrenia (2000) (10)
Red cell membrane fatty acids in schizophrenic patients with mainly positive or mainly negative symptoms (1993) (10)
Nutritional adequacy of human breast milk for prematurely born infants. (1989) (10)
A 4π plastic scintillation detector (1968) (10)
Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration. (1976) (10)
Letter: Diabetic retinopathy and prolactin. (1974) (10)
Short-term diabetes increases triacylglycerol arachidonic acid content in the rat liver. (1987) (10)
Liver delta 5 and delta 6 desaturase activity differs among laboratory rat strains. (1994) (10)
The effect of dietary n−6 and n−3 polyunsaturated fatty acids on blood pressure and tissue fatty acid composition in spontaneously hypertensive rats (1989) (10)
Effects of albumin on fatty acid, protein, and eicosanoid levels in rat mesenteric arterial bed perfusions. (1988) (10)
Human milk and the small baby. (1982) (10)
Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study. (2004) (10)
Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats Published, JLR Papers in Press, July 1, 2003. DOI 10.1194/jlr.M300217-JLR200 (2003) (10)
Altered arachidonic acid content in polymorphonuclear and mononuclear cells from patients with allergic rhinitis and/or asthma (2006) (10)
Commentary on Breast-Feeding and Infant Formulas, Including Proposed Standards for Formulas (1976) (10)
Tuberculous abscess at the site of penicillin injections. (1949) (10)
Adrenic acid delta 4 desaturation and fatty acid composition in liver microsomes of spontaneously diabetic Wistar BB rats. (1994) (10)
The Treatment of Idiopathic Recurrent Urolithiasis With Fish Oil and Evening Primrose Oil — A Double-Blind Study (1994) (10)
Abnormalities in Plasma Essential Fatty Acid Levels in Women with Premenstrual Syndrome and with Non-malignant Breast Disease (1991) (10)
Lithium γ‐linolenate‐induced cytotoxicity against cells chronically infected with HIV‐1 (1993) (10)
(Prostaglandins, Leukotrienes Med., 24:151-161)Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: The effect of glucose and insulin (1986) (10)
Effects of calcium deprivation on n-6 fatty acid metabolism in growing rats. (1988) (10)
Proceedings: Is prolactin a fluid and electrolyte regulating hormone in man? (1975) (9)
The grants game (1989) (9)
High altitude pulmonary oedema: pathophysiology and recommendations for prevention and treatment. (1972) (9)
Lowering cholesterol concentrations and mortality (1990) (9)
Myotonic dystrophy: a disease caused by functional zinc deficiency due to an abnormal zinc-binding ligand? (1980) (9)
Cytosolic phospholipase A2 type IVA is present in human red cells. (2004) (9)
Deuterium oxide as a tracer for measurement of compliance in pediatric clinical drug trials. (1989) (9)
An ELISA method for type IV cPLA2 in RBC: A potential marker for schizophrenia (2000) (9)
Liver Δ5 and Δ6 desaturase activity differs among laboratory rat strains (1994) (9)
NUTRITIONAL IMPLICATIONS OF THE WHOLE BODY COUNTER. (2009) (9)
DNA-protein and membrane-lipid: competing paradigms in biomedical research. (1995) (9)
The paradox of antioxidants and cancer. (2001) (9)
Vitamin D and infantile hypercalcemia. (1968) (9)
Prostaglandin precursors in plasma phospholipids of patients with psoriasis: effects of treatment with coal tar. (1984) (9)
Mediastinal emphysema and pneumothorax following tracheotomy (1943) (9)
New drug discovery techniques are not so revolutionary (2001) (9)
Pathophysiology of pre-eclampsia and of eclampsia. (1971) (9)
(IRCS Med. Sci., 14:180-181)Effect of dexamethasone on the distribution of essential fatty acids in plasma and liver phospholipids (1986) (9)
Fatty acid metabolism in health and disease : the role of Δ-6-desaturase. Discussion (1993) (9)
CHANGES IN BONE SODIUM DURING GROWTH IN THE RAT. (1963) (9)
Fluoride Supplementation: Revised Dosage Schedule (1979) (8)
(Prostaglandins, Leukotrienes Med., 15:223-228)Effect of dietary deletion and repletion of linoleic acid on renal fatty acid composition and urinary prostaglandin excretion (1984) (8)
Myo-inositol in physiological concentrations stimulates production of prostaglandin-like material. (1977) (8)
Determination of Total Body Sodium in Man with Radiosodium $sup 2$$sup 4$ (1949) (8)
A possible new mechanism of action of aspirin and other non-steroidal antiinflammatory drugs: inhibition of essential fatty acid metabolism (1986) (8)
Theophylline and bronchospasm. (1977) (8)
Lipid-lowering drugs and violence (1989) (8)
[Effects of omega-3-fatty acids on the prostaglandin system in healthy probands]. (1989) (8)
Is the triene/tetraene ratio always a valid indicator of functional essential fatty acid deficiency? (1981) (8)
Determination of sodium in bone with the aid of cation exchange chromatography. (1955) (8)
Stress Modulates Cholesterol-Induced Changes in Plasma and Liver Fatty Acid Composition in Rats Fed N-6 Fatty Acid-Rich Oils (1990) (8)
Study of plasma and red cell phospholipid fatty acids in extrahepatic cholestatic jaundice. (1994) (8)
Bone Sodium and Na22 Exchange (1959) (8)
Essential fatty acids in the liver and adipose tissue of genetically obese mice: effect of supplemental linoleic and gamma-linolenic acids. (1985) (8)
Aberrant leucocytozoon infection in parakeets (1972) (8)
Lipids and schizophrenia (1999) (8)
Essential fatty acid supplementation in atopic dermatitis (1993) (8)
Action of Tonin on the Response of Rat on Mesenteric Vessels to Norepinephrine 1 (1977) (8)
TOWARD A NEW DIMENSION IN HUMAN GROWTH Borden Award Address, October, 1964 (1965) (8)
The use of gamma-linolenic acid in diabetic neuropathy. (1992) (8)
Brain uptake and utilization of fatty acids: Applications to peroxisomal biogenesis disorders (An International Workshop): Roundtable discussion of session 3: The regulation and functions of DHA in neurons and neuronal membranes (2001) (8)
Short-Term Effect of Dietary Cholesterol on Tissue n-6 Fatty Acids in Fat-Deficient Rats (1985) (8)
Ultra-violet radiation and 8-methoxypsoralen have actions similar to those of known inhibitors of thromboxane A2 synthesis in rat mesenteric blood vessels. (1978) (8)
Concentration- and time-dependent effects of gamma-linolenic acid supplementation to tumor cells in culture. (1999) (8)
Overnutrition for the child: blessing or curse? (2009) (8)
Estimation of Total Body Chloride in Young Infants by Radiobromide Dilution.∗ (1953) (8)
Membrane fatty acid composition of fibroblasts from schizophrenic patients (1994) (8)
Essential fatty acid metabolism in long term primary cultures of rat cardiomyocytes: a beneficial effect of n-6:n-3 fatty acids supplementation (1999) (8)
A Diet Enriched in α-Lipoic Acid Reverses the Age-Related Compromise in Antioxidant Defences in Rat Cortical Tissue (2000) (7)
The mechanism of coronary artery spasm: roles of oxygen, prostaglandins, sex hormones and smoking. (1979) (7)
Polyunsaturated Fatty Acids and Human Cancer (1989) (7)
Metabolic Response to Growth Hormone Administration, with Particular Reference to the Occurrence of Hypercalcuria (1972) (7)
Essential Fatty Acids, Immunity and Viral Infections (1990) (7)
CHLOROQUINE AS PROSTAGLANDIN ANTAGONIST IN TREATMENT OF PATENT DUCTUS ARTERIOSUS (1976) (7)
A defect in thromboxane A2 synthesis may be a factor predisposing to cancer. (1978) (7)
A multicentre trial of ethyl eicosapentaenoate in schizophrenia (2000) (7)
Progesterone interferes with the actions of prostaglandin (PG) E1 but not those of PGE2 or PGF2 alpha in a rat vascular preparation. (1979) (7)
Inorganic chemical heterogony in man and animals. (1955) (7)
Idiopathic Oedema and Prolactin (1976) (7)
Plasma, platelet, and aorta fatty acids composition in response to dietary n-6 and n-3 fats supplementation in a rat model of non-insulin-dependent diabetes. (1988) (7)
Dopamine supersensitivity, endorphin excess, and prostaglandin E1 deficiency: three aspects of the same schizophrenic elephant. (1978) (7)
(IRCS Med. Sci., 14:1069-1074)Interferons, phospholipid metabolism, immune responses and cancer (1986) (7)
The companionship of lean and fat: some lessons from body composition studies. (1990) (7)
An historical note on chemotherapy of bacterial infections (Gerhard Domagk). (1970) (7)
Effect of cholesterol supplementation on plasma and liver cholesteryl ester fatty acids in rats fed casein or soy protein (1986) (7)
Deficient conversion of linoleic acid. (1990) (7)
Toward a new dimension in human growth. (1965) (7)
Fluids and electrolytes--clinical aspects. (1996) (7)
Natural killer cell functions are related to the cell membrane composition of essential fatty acids: differences in healthy persons and patients with primary Sjögren's syndrome. (1992) (7)
Letter to the Editor (1984) (7)
TREATMENT OF STAPHYLOCOCCIC PNEUMONIA AND EMPYEMA WITH PENICILLIN: Report of Six Cases, Two with Pulmonary Pneumatocele (1948) (7)
Effect of mercuric chloride on the rat mesenteric vascular bed: relevance to the mechanism of mercury toxicity. (1979) (7)
Differences in the metabolism of 18:2n-6 and 18:3n-6 by the liver and kidney may explain the anti-hypertensive effect of 18:3n-6. (1994) (7)
A possible relationship between dyslexia and schizophrenia, two disorders in which membrane phospholipid (PL) metabolism is disturbed (1996) (6)
Dopamine enhances the action of prolactin on rat blood vessels. Implications for dopamine effects on plasma prolactin. (1977) (6)
The use of sulfamerazine in infants and children. (1946) (6)
Letter: Prolactin and myocardial infarction. (1973) (6)
Myasthenia and prostaglandin E1. (1979) (6)
Unmeasured losses of potassium in balance studies. (1983) (6)
Chapter 3 The lipid hypothesis of schizophrenia (2002) (6)
Body Composition of Adolescent Girls (1991) (6)
In vivo and in vitro biotransformation of the lithium salt of gamma-linolenic acid by three human carcinomas. (1997) (6)
Vascular actions of frusemide and bumetanide on the rat superior mesenteric vascular bed: interactions with prostaglandins. (1976) (6)
Effect of dietary olive oil non-glyceride fraction on plasma cholesterol level and liver phospholipid fatty acid composition (1991) (6)
Effect of dietary alpha- and gamma-linolenic acid on tissue fatty acids in guinea pigs. (1985) (6)
gamma-Linolenic acid supplementation can affect cancer cell proliferation via modification of fatty acid composition. (1996) (6)
Potatoes: A Reliable Source of Vitamin C (1993) (6)
Effects of high vitamin a intake on plasma and liver phospholipid and triglyceride fatty acid compositions in hamsters (1985) (6)
Possible Roles of Prostaglandins in Mediating Opioid Actions (1982) (6)
Effect of dietary cholesterol on the release of prostacyclin from the mesenteric vascular bed in diabetic rat. (1987) (6)
In vitro hydrolysis of polyunsaturated fatty acid N-acyloxymethyl derivatives of theophylline (1998) (6)
Effect of Low Sodium Diet on Sodium Content and Radiosodium Exchange in Rat Bone.∗ (1958) (6)
Zinc, acrodermatitis, acne, and prostaglandins. (1977) (6)
Blood tin concentrations in Alzheimer's disease (1992) (6)
Linoleic acid-induced fatty acid changes in platelet and aorta of the rat: Effect of age and cholesterol (1988) (6)
Selective incorporation of n-3 and n-6 fatty acids in essential fatty acid deficient rats in response to short-term oil feeding. (1987) (6)
The effect of n-6 fatty acids on normal and v-Ki ras transformed NIH-3T3 cells. (1992) (6)
D.V.T. after vitamin C? (1973) (6)
The Use of Sulfa-pyrazine in Infants and Children. (1943) (6)
Probable role of zinc in the mobilization of dihomo-γ-linolenic acid and in the desaturation of linoleic acid (1981) (6)
Longitudinal changes in adult body composition: influence of body weight. (1998) (6)
A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels. (2003) (6)
The Assumptions of Science (1969) (6)
Polyunsaturated Oils of Marine and Plant Origins and Their Uses in Clinical Medicine (1989) (6)
The effects of short term dietary supplementation with evening primose of safflower oil on fatty acid and prostaglandin release from perfused mesenteric vascular beds in spontaneously hypertensive rats (1988) (6)
Effect of cholesterol feeding and sex difference on the tissue n-6 and n-3 fatty acid levels in fat-deficient rats treated with linoleate or linolenate (1985) (6)
THE EFFECT OF PROLACTIN ON THE RESPONSE OF HUMAN LYMPHOCYTES TO PHYTOHAEMAGGLUTININ (1976) (6)
Sarcoidosis of the gall bladder. (1965) (5)
DIAZEPAM AS TUMOUR PROMOTER (1981) (5)
Modification of the fatty acid binding profile of liver fatty acid binding protein (L-FABP) (1993) (5)
Determination of Specific Activity of Sodium in Bone.∗ (1955) (5)
Post-natal development of sympathetic innervation in the rabbit heart. (1975) (5)
A Guide to Kenya and Northern Tanzania (1971) (5)
(Atherosclerosis, 41:193-207)Most biological effects of zinc deficiency corrected by gamma-linolenic acid (18:3n-6) but not by linoleic acid (18:2n-6) (1981) (5)
International research communication system. (1973) (5)
Comparison of the metabolism of alpha-linolenic acid and its delta 6 desaturation product, stearidonic acid, in cultured NIH-3T3 cells. (1993) (5)
Flowers and Trees (1971) (5)
Histoplasmin and tuberculin sensitivity in Texas infants and children. (1953) (5)
Zinc, essential fatty acids, and prostaglandins. (1979) (5)
Reflections of dietary studies with children in the ten-state nutrition survey of 1968-1970. (1975) (5)
Unsaturated lipids: a new approach to the treatment of cancer. (1994) (5)
Plasma lipoproteins and apolipoproteins in individuals convicted of violent crimes. (1997) (5)
Evidence-Based Medicine and the Need for Non-Commercial Clinical Research Directed Towards Therapeutic Innovation (2002) (5)
Response of bone sodium to acute changes in extracellular fluid composition (cat). (1958) (5)
Letter to the Editor: Vitamin D in Pregnancy and the Infantile Hypercalcemic Syndrome (1979) (5)
(Lipids, 21:652-656)The influence of dietary manipulation with n-3 and n-6 fatty acids on liver and plasma phospholipid fatty acids in rats (1986) (5)
Effects of eicosapentaenoic acid and arachidonic acid on incorporation and metabolism of radioactive linoleic acid in cultured human fibroblasts. (1991) (5)
Frusemide as inhibitor of prolactin action. (1973) (5)
Effect of dietary linoleic acid content on the distribution of triacylglycerol molecular species in rat adipose tissue (1992) (5)
The influence of phenelzine and tranylcypromine on the release of prostaglandins from the rat mesenteric vascular bed. (1988) (5)
The laryngeal swab in early and convalescent cases of pulmonary tuberculosis. (1948) (5)
Impaired platelet aggregation and thromboxane generation in essential fatty acid-deficient rats. (1987) (5)
Fatty acid composition of tissue phospholipids in essential fatty acid deficient guinea pigs (1984) (5)
Iron overload in three generations of a family with hemoglobin Olympia. (1984) (5)
Zinc, penicillamine, and prostaglandin E1. (1978) (5)
Multielement and lipid analysis of blood in alcoholic subjects (1989) (5)
The prostaglandin outflow from perfused mesenteric vasculature of rats fed different fats. (1989) (5)
Inhibition of neutrophil respiratory burst and cytokine priming by gamma-linolenic acid. (1996) (5)
Why is speculation so awful? (2000) (5)
Effects of cholesterol on viability and (n - 6) fatty acid metabolism in cultured human monocyte-like cells (U937). (1992) (5)
Influence of omega-3 fatty acids on the prostaglandin-metabolism in healthy volunteers and patients suffering from PVD. (1992) (5)
Effect of essential fatty acid depletion on tissue phospholipid fatty acids in spontaneously hypertensive and normotensive rats (1989) (5)
NECROBACILLOSIS IN MAN (1944) (5)
Effects of Maternal Dietary n-3 and n-6 Fatty Acids (Pre- and Post-Δ6 Desaturation) on Tissue Glycerophospholipid Fatty Acid Compositions in Dams and Suckling Mice (1993) (5)
Effect of fasting on the distribution of triacylglycerol molecular species in rat liver (1992) (5)
Seafoods and fish oils in human health and disease: John E. Kinsella Marcel Dekker, New York and Basel, 1987; 317 pp.; $99.75 (U.S.A. & Canada), $119.50 (elsewhere); ISBN 0-8247-7771-9 (1989) (4)
Comparison of short-term feeding of dietary linoleic and gamma-linolenic acid on plasma and liver cholesterol and fatty acids in hyperchol esterolemic rats (1988) (4)
Plasma bromine concentrations and lipid profiles. (1991) (4)
The potato's placement in the dietary pyramid. (1999) (4)
Interactions between dopamine and prostaglandins on vascular reactivity to noradrenaline: dopamine inhibits the action of PGE1. (1981) (4)
Ideas in biomedical science: reasons for the foundataion of Medical Hypotheses. (1975) (4)
Exercise and body composition revisited: the effect of body weight change. (1998) (4)
(IRCS Med. Sci. (Biochem.), 13:1145-1146)Effect of diabetes on the metabolism on n-3 and n-6 fatty acids in rats (1985) (4)
Exogenous gamma-linolenic acid alters hormone stimulated cyclic AMP levels in U937 cells. (1996) (4)
In vitro hydrolysis of novel gamma-linolenoyloxyalkyl derivatives of theophylline (1997) (4)
(Biochem. Med. Metab. Biol., 49:057-066)Effect of salt-loading and spontaneous hypertension on in vitro metabolism of [1-14C]-linoleic and [2-14C]-dihomo-γ-linolenic acids (1993) (4)
Total body potassium and lean body mass in patients with Duchenne dystrophy and their female relatives. (1970) (4)
Prostaglandin E1: physiological significance and clinical use. (1988) (4)
Peer review of statistics in medical research. Rationale for requiring power calculations is needed. (2002) (4)
Do we need a new perspective in infant nutrition (1958) (4)
The international handbook of medical science. (1972) (4)
Indomethacin, prostaglandins, and schizophrenia. (1977) (4)
Evening primrose oil and atopic eczema (1995) (4)
Dietary nutrients and plasma n-3, n-6, saturated and monounsaturated fatty acids (1997) (4)
The membrane hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia (1998) (4)
Essential fatty acids and the complications of diabetes mellitus. (1989) (4)
Altered arachidonic acid content in polymorphonuclear and mononuclear cells from patients with allergic rhinitis and/or asthma (2007) (4)
A theory of hypertension. (1966) (4)
Long-term behavior of radiosodium in bone: Comparison with radiocalcium and effects of various procedures (2005) (4)
Effects of linoleic and gamma-linolenic acids (efamol evening primrose oil) on fatty acid-binding proteins of rat liver (2004) (4)
CARBON DIOXIDE AND ACUTE MOUNTAIN SICKNESS (1988) (4)
Schizophrenia and membrane lipids. (1997) (4)
Effect of gamma-linolenic acid on plasma and membrane lipids and renal prostaglandins in old subjects. (1999) (4)
(Biochem. Med. Metab. Biol., 51:027-034)Differences in the metabolism of 18:2n 6 and 18:3n 6 by liver and kidney may explain the anti-hypertensive effect of 18:3n 6 (1993) (4)
An Introduction to Human Physiology (1973) (4)
(Biochem. Med. Metab. Biol., 40:061-067)Effect of calcium deprivation on n-6 fatty acid metabolism in growing rats (1988) (4)
Effects of evening primrose oil in rheumatoid arthritis. (1989) (4)
The role of a prostaglandin E1 deficiency in schizophrenia: interactions with dopamine and opiates (1980) (4)
Body Composition of the Fetus (1987) (4)
Effect of n-3 and n-6 fatty acids on hepatic microsomal lipid metabolism: a time course study (1992) (4)
Bone mineral turnover in a patient with osteogenesis imperfecta estimated by fluoride excretion (1978) (4)
Blood Pressure Levels of Children 6-11 Years: Relationship to Age, Sex, Race and Socioeconomic Status, United States: Vital and Health Statistics (1974) (4)
Pediatric and adolescent endocrinology. (1980) (3)
Letter: Prolactin and pre-eclampsia. (1975) (3)
Essential Physiology (1973) (3)
Postadrenalectomy pituitary adenoma (Nelson's syndrome) in childhood: clinical and roentgenologic detection. (1976) (3)
Effects of prolactin and suppression of prolactin secretion on experimental tumours of lung and muscle in mice. (1977) (3)
Effects of dietary protein and cholesterol on phosphatidylcholine and phosphatidylethanolamine molecular species in mouse liver (2006) (3)
Science is God (1970) (3)
Genetic factors in abdominal obesity, a risk factor for stroke. (1988) (3)
Influence of different dietary fatty acid sources on erythrocyte lipids and plasma and liver essential fatty acids in hamsters fed ethanol. (1986) (3)
Actions of prolactin and frusemide on cardiac rate and rhythm. (1974) (3)
Letter: Prolactin, bromocriptine, and haemostasis. (1975) (3)
Relationship between mouse liver Δ9 desaturase activity and plasma lipids (1993) (3)
Indocyanine green clearance test for screening liver function in normal and pre-eclamptic women. (1973) (3)
Maintenance energy needs for women as a function of body size and composition. (1989) (3)
Metabolism of n-6 fatty acids by NIH-3T3 cells transfected with the ras oncogene (1994) (3)
Prolactin and mental illness. (1974) (3)
Lactic acidosis, prostaglandin E1, and colchicine. (1978) (3)
Basic principles of control (1970) (3)
Essential Fatty Acids in the Management of Diabetic Neuropathy (1996) (3)
Immunological deficiency, cancer, and prostaglandins. (1977) (3)
Magnesium and malnutrition. (1967) (3)
Phospholipids, niacin skin test and type IV cPLA2 in schizophrenia (2000) (3)
The communication systems of the body (1964) (3)
The juvenile diabetic. (1956) (3)
Effect of repeated periods of freezing and thawing on fatty acid composition of red blood cells and plasma (1992) (3)
186 Skin flushing in response to graded doses of topical niacin: A new test which distinguishes schizophrenics from controls (1997) (3)
The subcutaneous administration of sodium sulfadiazine. (1947) (3)
Dietary Supplementation with Zinc Sulphate, Sodium Selenite and Fatty Acids in Early Dementia of Alzheimer's Type. II: Effects on Lipids (1991) (3)
Effect of glucose and insulin on release of prostaglandins from the mesenteric vascular bed in control and streptozotocin diabetic animals (1986) (3)
DIAZEPAM AND BREAST CANCER (1981) (3)
Selective control of formation of 1 and 2 series prostaglandins: a new concept in the regulation of inflammation and immunity (1980) (3)
EFFECTS OF EICOSANOID PRECURSORS ON TBA REACTIVE MATERIAL IN NORMAL AND MALIGNANT CELLS (1987) (3)
Plasma prolactin levels during a simulated dive. (1976) (3)
Fatty acid derivatives (1942) (3)
Effects of polyunsaturated fats on plasma and liver cholesteryl ester composition in hypercholesterolemic rat (1986) (3)
Innovative approaches to cancer. (1979) (3)
Essential fatty acid metabolism in cardiomyocytes grown in media enriched with different N‐6/N‐3 fatty acid combinations (1997) (3)
Premenstrual Syndrome and Pregnancy Toxemia (1973) (3)
The possible role of prolactin in pre-eclampsia. (1975) (3)
CRYPTOCOCCOSIS IN A CAT. (1965) (3)
Iatrogenic femoral neuropathy. (1976) (3)
Lithium and Dermatological Disorders (1990) (3)
The pituitary and hypothalamus (1971) (3)
Aluminum, cadmium, lipids and prevalence of dementia in people living near an aluminum smelter (1993) (3)
Interactions of zinc with prostaglandins E1 and E2 in vascular smooth muscle. (1981) (3)
Zinc deficiency, reduced food intake and essential fatty acids. (1985) (3)
The philosophical basis of drug target selection (1996) (3)
["Antiepileptic therapy" rickets roentgenologic implications]. (1974) (3)
Effect of dietary linoleic acid content on the distribution of phosphatidylcholine molecular species in rat plasma (1994) (3)
The roles of prostaglandins and prolactin in depression, mania and schizophrenia. (1977) (3)
Colchicine therapy. (1978) (3)
Prolactin and Fluid and Electrolyte Balance and the Cardiovascular System (1973) (3)
Fatty acid changes in liver choline and ethanolamine glycerophospholipids in aspirin-treated rats fed linoleate, gamma-linolenate and fish oil. (1989) (3)
15 – Lithium and Essential Fatty Acid Metabolism in Psychiatric Disorders, Herpes Virus Infections and Seborrhoeic Dermatitis (1991) (3)
Adenosine as a prostaglandin antagonist. Possible mechanism of the defect in combined immunodeficiency disease due to adenosine deaminase deficiency. (1978) (3)
Immunoglobulin production and eicosanoid precursors in patients with primary Sjögren's syndrome. (1995) (2)
Manipulation of lipid composition of rat heart myocytes aged in culture and its effect on alpha1-adrenoceptor stimulation. (1997) (2)
Publication time. (1974) (2)
Ethical imperative to publish extends to academics too (1995) (2)
High levels of polyunsaturated fat may inhibit cancer growth (1996) (2)
Prostaglandins and schizophrenia. (1980) (2)
The Protection of Wild Life (1971) (2)
(Biochem. Biophys. Res. Commun., 145:015-024)Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro (1987) (2)
ARGININOSUCCINIC ACIDURIA: A SURVIVOR OF THE NEONATAL VARIANT (1977) (2)
Why do we not make more medical use of nutritional knowledge? How an inadvertent alliance between reductionist scientists, holistic dietitians and drug-oriented regulators and governments has blocked progress. (2003) (2)
Effects and clinical significance (1976) (2)
Impaired niacin flushing in schizophrenia: Possible biochemical mechanisms (2003) (2)
Relationship between mouse liver delta 9 desaturase activity and plasma lipids. (1993) (2)
Treatment of hyperthyroidism withradioactive iodine (1951) (2)
Effects of omega-3 fatty acids on the prostaglandin system in healthy volunteers. (1989) (2)
Serum copper levels are elevated in seborrhoeic dermatitis (1989) (2)
Essential fatty acid supplementation during early alcohol abstinence. (1987) (2)
Abbreviated Writing. (1975) (2)
National Parks and Reserves of Kenya (1971) (2)
190. Membrane deficits in schizophrenia (2000) (2)
Percent body fat derived from skinfold thickness measurements. (1990) (2)
The Kenya Coast (1971) (2)
Nutrition and hyperactivity. (1982) (2)
Prostaglandins and the ductus arteriosus. (1977) (2)
(Prog. Lipid Res., 25:499-501)Increased release of prostaglandins from the mesenteric vascular bed in streptozotocin diabetes (1986) (2)
The reasons for starting a new journal on prostaglandins. (1978) (2)
FACTORS AFFECTING FOOD INTAKE: COMMITTEE ON NUTRITION, AMERICAN ACADEMY OF PEDIATRICS. (1964) (2)
Food Fads: Safe Feeding of Children (1980) (2)
376. Eicosanoid pathways and psychiatric disorders (2000) (2)
Age-associated reduction of prostacyclin and thromboxane synthesis is inversely related to plasma cholesterol levels: modulation by dietary cholesterol supplementation. (1990) (2)
Tin and low-density lipoprotein fatty acids in plasma from patients with acute myocardial infarction (1997) (2)
Selective Cytotoxicity of Certain Essential Fatty Acids Towards Tumour Cells (1993) (2)
Survival during fasting. (1983) (2)
Effects of saturated fatty acids on n-6 fatty acid metabolism in cultured human monocyte-like cells (U937) (1993) (2)
Metabolism of radiolabelled 18:2n-6 and 18:3n-6 by NIH-3T3 cells and the DT subclone. (1993) (2)
Should Milk Drinking by Children Be Discouraged? (1974) (2)
PLATELETS, LIPIDS, AND MYOCARDIAL INFARCTION (1977) (2)
PROTEOLYTIC enzymes in milk in relation to infant feeding. (1959) (2)
Plasma thiols, cognitive function and ageing. (1996) (2)
The fetus and child (1973) (2)
Response of Bone Sodium to Acute Changes in Serum Sodium (1961) (2)
Progesterone and blood pressure. (1972) (2)
A new mechanism of tricyclic antidepressant action. Blockade of prostaglandin-dependent calcium movements. (1977) (2)
Gamma linolenic acid up-regulates e-cadherin expression in human cancer cells (1995) (2)
Insects and their Allies (1971) (2)
Response of Cartilage Sodium to Changes in Extracellular Fluid.∗ (1960) (2)
BONE RESORPTION BY BREAST-CANCER TISSUE (1976) (2)
Essential fatty acid supplementation inhibits the effect of dietary zinc deficiency. (1980) (2)
Partial reversal of plasma and red cell essential fatty acid abnormalities in chronic urticaria with evening primrose oil (1990) (2)
Letter: Sex difference in cardiac actions in prolactin. (1974) (2)
PROLACTIN AND MIGRAINE (1974) (2)
Low-density lipoprotein fatty acids in patients with acute myocardial infarction (1999) (2)
Plasma and red cell cadmium, vanadium and tin in treated hypertensives (1992) (2)
Dilinoleoyl-mono-gamma-linolenin (DLMG) and Digamma- linolenoyl-monolinolein (DGML): Naturally Occurring Structured Triacylglycerols in Evening Primrose Oil (1998) (2)
63-3 Clozapine: Elevation of membrane unsaturated lipid levels as a new mechanism of action (1997) (2)
Effect of Dietary Oils Enriched in Dilinoleoyl-Mono-Gamma-Linolenin (DLMG) on the Total Lipid n-6 Fatty Acid Composition of Human Tumors Grown in Nude Mice (1998) (2)
Selective regulation of the synthesis of 1 and 2 series prostaglandins: A new concept in the nutritional and pharmacological regulation of immunity (1980) (2)
In memoriam: Sukdeb Mukherjee MD, 1946–1995 (1996) (2)
Effects of repeated gestation and lactation on milk n-6 fatty acid composition in rats fed on a diet rich in 18:2n-6 or 18:3n-6 (1992) (2)
Uptake and elution of radiosodium in bone powder: Comparison with47Ca and85Sr (2005) (1)
Use of gamma-linolenic acid and related compounds in the treatment of complications of diabetes mellitus (1986) (1)
Prolactin: Role in Health and Disease (1979) (1)
Myo-inositol in physiological concentrations stimulates production of prostaglandin like material (1978) (1)
Interactions between lipid metabolism and schizophrenia: The biochemical changes which may have made us human (2007) (1)
Oral contraceptives and malignant hypertension. (1969) (1)
The female sex cycle. (1969) (1)
Prevention of dietary effects of zinc deficiency by administration of essential fatty acids [proceedings]. (1979) (1)
Lipid peroxide and schiff reactive material produced by GLA-treated cancer cells (1990) (1)
More on burns after photodynamic therapy. Might doctors performing the study have been given the wrong injection instructions? (2001) (1)
Lithium gamma-linolenate-induced cytotoxicity against cells chronically infected with HIV-1. (1993) (1)
The Role of Prolactin in Human Physiology and Disease (1973) (1)
Drugs Which Alter Prolactin Secretion (1973) (1)
Interation between prostaglandins and calcium: The importance of bell-shaped does-response curves (1978) (1)
Principles of biological control (1970) (1)
Evening primrose oil and premenstrual syndrome (1990) (1)
Practical Endocrine Diagnosis (1979) (1)
A. Ashley Weech, MD. (1972) (1)
Advertising claims for The Lancet (1999) (1)
Editorial: A revolutionary concept of the role of the nucleolus in cell division and its relevance to stem cell proliferation, cancer and ageing (1980) (1)
Response of bone to alloxan-diabetic acidosis in the rat. (1958) (1)
The Nature of Scientific Research (1969) (1)
(Mol. Cell. Biochem., 118:153-161)Effect of n-3 and n-6 fatty acids on hepatic microsomal lipid metabolism: a time course study (1992) (1)
Membrane essential fatty acids (EFAS) show a biphasic distribution in schizophrenics with predominantly positive or predominantly negative symptoms (1992) (1)
Prolactin and Cancer (1973) (1)
HANDBOOK OF SENSORY PHYSIOLOGY: Vol. 2: SOMATOSENSORY SYSTEM Ed. A. IGGO Springer‐Verlag, Berlin 1973. Pp. xi+ 851. DM 262 (1974) (1)
Phospholipases as candidate genes in schizophrenia (2000) (1)
Letter: Thyrotrophin-releasing hormone, prolactin, and cholesterol. (1973) (1)
Adult decline in lean body mass. [/sup 40/K tracer technique] (1976) (1)
Effects of Metabolic and Environmental Stimuli on Prolactin Secretion (1973) (1)
The effects of lithium gamma-linolenic acid in reversing LPBM5 MuLV induced suppression of hematopoietic progenitor cells in vitro. (1998) (1)
VITAMIN E TREATMENT OF TARDIVE DYSKINESIA. REPLY (1993) (1)
Phospholipid metabolism and pregnancy-related events which enhance risk of schizophrenia (2000) (1)
Assay of Prolactin (1973) (1)
Effects of gammalinolenic acid (GLA) and eicosapentaenoic acid (EPA) on bone calcium and on urinary collagen cross link excretion in young male rats (1995) (1)
14-34 Trait anxiety is associated with high arachidonic acid levels in plasma — a study of men born in 1933 (1997) (1)
Systems with multiple detectors and multiple effectors (1970) (1)
Long-term administration drugs and the deMopment of antiepileptic of rickets (1972) (1)
Obituary: Sir John Eccles (1903-1007). (1997) (1)
The role of dietary fat in bone and joint health (2003) (1)
Natural and Drug-Induced Parkinsonism (1973) (1)
Isolation, Structure and Cells of Origin (1973) (1)
n -6 Fatty acids and atopic eczema (1998) (1)
Science, Volume 133, 1961: Estimation of total body fat from potassium-40 content. (1991) (1)
Biochemistry and Effects on Metabolism (1973) (1)
Treatment of lithium-induced tremor and familial essential tremor with essential fatty acids. (1981) (1)
Iron Enrichment of Food (1974) (1)
Acceptance of the Howland Award (1992) (1)
Lipid aspects of essential fatty acid deficiency in the hamster: comparison of various fat sources (1986) (1)
Is obesity a genetic disease? (1982) (1)
Christmas Books: Quirks of fate? (1978) (1)
Prolactin in Male and Female Reproduction (1973) (1)
On the matter of ethnic differences in body composition. (2001) (1)
Isotopes and radioactivity (1971) (1)
The possible role of prostaglandin E1 deficiency in the immunological abnormalities seen in schizophrenia (1980) (1)
Overestimation of Nutritional Requirements; Leucine-Sensitive Hypoglycemia (1965) (1)
Variations in temperature and oxygen content do not alter levels of thiobarbiturate reactive material in human breast tumour cells (ZR-75-1) incubated with gamma-linolenic acid. (1993) (1)
Effect of growth hormone on fluoride balance (1973) (1)
Abnormal indocyanine green clearance test and pre-eclampsia. (1973) (1)
Metabolism of marine N-3 fatty acids in diabetic and in cholesterol-fed essential fatty acid deficient rats: possible activation of delta-4-desaturase activity (1987) (1)
TUBERCULOUS ABSCESS AT THE SITE OF INJECTIONS (1949) (1)
ALEXIS FRANK HARTMANN, SR.: AN APPRECIATION. (1964) (1)
Nutrition in relation to problems of radioactivity. (1962) (1)
Weight loss during fasting (1971) (1)
90-96 Depletion of docosahexanoic acid in erythrocyte membranes of depressive patients (1997) (1)
520 FOLLOW-UP OF ESOPHAGEAL FUNCTION IN REPAIRED ESOPHA GEAL ATRESIA (1981) (1)
Serum concentrations of bromine and tin in hypertension and depression (1991) (1)
Membrane phospholipid abnormalities as a biochemical basis for the neurodevelopmental concept of schizophrenia (1998) (1)
Fatty acid coenzyme a ligases as candidate genes in schizophrenia (2000) (1)
Phospholipid and Fatty Acid Metabolism in Schizophrenia and Depression (2003) (1)
Reduced neuronal membrane phospholipid turnover and normalization of blood fatty acids associated with symptom remission in a patient with schizophrenia treated solely with eicosapentaenoic acid (2000) (1)
Coronary Artery Disease and Progesterone (1978) (1)
(Med. Sci. Res., 15:161-162)Effect of long-term dietary cholesterol supplementation on fatty acid composition and platelet aggregation in the rat (1987) (1)
Influence of Trauma and Disease (1987) (1)
(Nutr. Rep. Int., 39:1275-1287)A time course study on differential depletion of n-6 and repletion of n-3 and n-9 long chain polyunsaturated fatty acids in liver, heart and kidney glycerophospholipids from rats fed saturated fat and fish oil (1989) (1)
Letter: Short-term starvation in infancy re subsequent learning disabilities--a proven relationship? (1976) (1)
Negative and positive feedback (1970) (1)
DENTAL caries and a consideration of the role of diet in prevention. (1959) (1)
519 PROTEIN SPARING MODIFIED FAST IN OBESE ADOLESCENTS: LONG TERM EFFECT ON LEAN BODY MASS (1981) (1)
Letter: On the joule. (1975) (1)
Arachidonic acid (AA) deficiency is independently associated with abnormal involuntary movements (AIMS) in the general population.— A study of men born in 1933 (1996) (1)
The Land and its Climate (1971) (1)
Potassium content of fat-free body mass. (1984) (1)
Prostaglandin I2 (prostacyclin) inhibits intracellular calcium release [proceedings]. (1978) (1)
Body composition in adolescent pregnancy: Relationship to birthweight (1990) (1)
Metabolic role of sodium in bone. (1959) (1)
Body composition derived from whole body counting of potassium in GH deficient adults. (1996) (1)
16, 16 dimethyl PGE2: evidence that it has properties different from the parent compound in vascular smooth muscle. (1980) (1)
Review by the Committee on Nutrition (1974) (1)
The cell and its requirements (1971) (0)
γ-Linolenic acid in diabetes. (2001) (0)
Rheumatoid Arthritis and Collagen Diseases (1973) (0)
ACTION OF PHENOBARBITONE IN PRE-ECLAMPSIA (1969) (0)
Action of phenobarbitone in preeclampsia. (1969) (0)
Health for the Visitor (1971) (0)
Application of control theory to a particular research problem—high arterial pressure (1970) (0)
The use of evening primrose oil (Efamol) in the management of breast pain [women]. [Conference paper] (1990) (0)
The febrile consulsion. (1954) (0)
Reviews and hypotheses in prostaglandins and medicine (1978) (0)
(Biochem. Arch., 02:133-141)The influences of dietary fats on liver docosahexaenoic acid levels in streptozotocin-induced diabetic rats (1986) (0)
National Parks and Reserves in Northern Tanzania (1971) (0)
Letter: Parkinsonism, growth hormone and prolactin. (1976) (0)
Omega-3-fatty acids improve in vivo and in vitro platelet function (1994) (0)
BODY COMPOSITIONAL CHANGES IN RESPONSE TO TESTOSTERONE. AUTHOR'S REPLY (1992) (0)
Zinc Decreases Lipid and Long Chain Fatty Acid Release from the Rat Mesenteric Vascular Bed Perfused in Vitro (1988) (0)
Essential biochemistry, endocrinology and nutrition : a guide to important principles for nurses and allied professions (1971) (0)
(Med. Sci. Res., 23:191-193)In vitro Effects of phosphatidylcholine on Δ6 desaturase activity and membrane fluidity in rat liver microsomes (1995) (0)
Forbes a Note on the Effect of Diet on Body Composition METHODS FOR DETERMINING COMPOSITION OF THE HUMAN BODY : With Services (2006) (0)
Body Fat and Physical Fitness (1978) (0)
Effect of estrogen on metabolic response to growth hormone. (Abstract only) (1976) (0)
The efficacy of combinative drugs at sub-threshold concentrations (1991) (0)
Polyunsaturated fatty acids and colchicine in multiple sclerosis. (1979) (0)
The toxicological consequences of short-term dietary essential fatty acid deficiency in rats (1994) (0)
Symposium on overnutrition; introductory remarks. (1961) (0)
Transactions of the Society for Pediatric Research: Thirty-First Annual Meeting, Atlantic City, N.J., May 4-5, 1961 (1961) (0)
Book Brief (1980) (0)
Acids, bases and buffers (1971) (0)
A time course study on differential depletion of N-6 and repleton of N-3 and N-9 long chain polyunsaturated fatty acids in liver, heart and kidney glycerophospholipids from rats fed saturated fats or fish oil (1989) (0)
Alteration of the behaviour of control mechanisms (1970) (0)
THE USE OF SULFAPYRAZINE IN INFANTS AND CHILDREN (1943) (0)
Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis 14 (2005) (0)
Verse—and Verse (1974) (0)
Obituaries: Linus Pauling and Karl Popper (1994) (0)
Effective clinical innovation (2002) (0)
The communication systems of the body [by] David F. Horrobin. (1964) (0)
The Thornbush Country (1971) (0)
THE NEPHROTIC syndrome. (1959) (0)
Gamma-linolenic acid or dihomo-gamma-linolenic acid-containing composition for improving the skin. (1989) (0)
(Proc. Soc. Exp. Biol. Med., 195:136-141)The effects of dietary cholesterol and stress on plasma and liver n-6 fatty acid composition in growing rats fed linoleate and γ-linolenate rich oils (1990) (0)
Prolactin and Thyroid Function (1973) (0)
Editorial: Ethics and Editors. (1974) (0)
Other Effects of Prolactin (1973) (0)
Science and Government (1969) (0)
The Epidemiology of Prematurity (1978) (0)
852 BONEMINERAL TURNOVER IN OSTEOGENESIS IMPERFECTA (1978) (0)
Human Growth: Body Composition, Cell Growth, Energy, and Intelligence, edited by Donald B. Cheek, M.B., B.S., M.D., and D.Sc. Philadelphia: Lea and Febiger, 1968, 781 pp., $25.00 (1969) (0)
Low prostaglandin concentrations cause cardiac rhythm disturbances. Effect reversed by low levels of copper or chloroquine (1978) (0)
Alexander Ashley Weech, MD Nov 10, 1895--Aug 17, 1977. (1977) (0)
Compositions and methods for treating magengeschwueren. (1988) (0)
Fatty acid ester as the bioactive compounds (1996) (0)
The business of research. (1972) (0)
The adrenal cortex (1971) (0)
"Controversy in pediatrics". (1974) (0)
Important substances in biochemistry (1971) (0)
Personal View (1974) (0)
HAZARDS OF HYPERTHYROIDISM (1966) (0)
65-114 Low arachidonic acid levels in dyskinesia — A study of men born in 1933 (1997) (0)
Framstaellning of fettsyramediciner (1992) (0)
Funding Research: State Carrot for Private Investment (1988) (0)
Phospholipid metabolism and perinatal events which lead to increased risk of schizophrenia (2000) (0)
Derivatives of antiviral nucleosides. (1990) (0)
Nairobi and Kenya East of the Rift (1971) (0)
P16 01 MP – SELECTIVE CYTOTOXICITY OF CERTAIN ESSENTIAL FATTY ACIDS TOWARDS TUMOR CELLS (1991) (0)
EFA preparations and the use thereof (1991) (0)
"Cgs" and a new editor. (1973) (0)
Science and Education (1969) (0)
PROGESTERONE AND PRE-ECLAMPSIA (1968) (0)
Bone mineral content in infants. (1987) (0)
Empyema. (1948) (0)
Discussion (1979) (0)
Human prolactin: clinical implications. (1978) (0)
Men and Migrations (1971) (0)
(Nutr. Res., 05:095-100)Effect of high vitamin A intake on plasma and liver phospholipid and triglyceride fatty acid composition in hamsters (1985) (0)
(IRCS Med. Sci. (Biochem.), 13:950-951)Changes in plasma and liver phospholipid fatty acids in cholesterol-fed diabetic rats (1985) (0)
Eicosanoid Precursors as Pharmaceuticals (2004) (0)
Essential fatty acid metabolism and its modification in atopic eczema 1 , 2 (0)
(Med. Sci. Res., 15:185-186)Effect of essential fatty acid deficiency on incorporation of vegetable n-6 and marine n-3 fatty acids by erythrocytes in rat (1987) (0)
The International Handbook of Medical Science. A Concise Guide to Current Practice and Recent Advances (1971) (0)
BURKITT'S TUMOUR, LYMPHOCYTES, AND PROLACTIN (1977) (0)
Unconventional Publication (1973) (0)
Blackwater fever in Kenya: problems of etiology. (1973) (0)
What should be Done about Schizophrenia? (1981) (0)
Utake and elution of radiosodium in bone powder: comparison with 47 Ca and 85 Sr. (1971) (0)
(Monographs on Atherosclerosis, 16:011-025)Effect of dietary protein and cholesterol on tissue cholesterol contents and n-6 fatty acid compositions in rats and mice fed a gamma-linolenate rich diet (1990) (0)
Interactions between cannabinoids and phsopholipid metabolism in schizophrenia (2000) (0)
The great denial. (1967) (0)
(Prostaglandin, 30:969-980)Effects of dietary saturated, n-6 and n-3 polyunsaturated fats on blood pressure and prostaglandin outflow from perfused mesenteric vascular bed in rats (1985) (0)
(Med. Sci. Res., 15:1207-1209)Plasma triacylglycerol fatty acids in diabetic rats fed gamma-linolenate and marine n-3 fatty acids (1987) (0)
Physics, chemistry, and biology. Introduction (1971) (0)
The body fluids (1973) (0)
Book Review Child and Adolescent Obesity: Causes and Consequences, Prevention and Management Edited by Walter Burniat, Tim J. Cole, Inge Lissau, and Elizabeth M.E. Poskitt. 416 pp., illustrated. Cambridge, United Kingdom, Cambridge University Press, 2002. $90. 0-521-65237-5 (2003) (0)
The international handbook of medical science : a daily reference book for medical practice (1972) (0)
The importance of osmotic pressure (1971) (0)
The niacin flush test in schizophrenia: Clinical and biochemical correlates (1996) (0)
Letter: Prolactin and prostaglandin synthesis. (1974) (0)
Textbook of Paediatric Nutrition (1978) (0)
Scientific Law and the Practice of Science (1969) (0)
Treatment of hyperthyroidism with radioactive iodine. (1951) (0)
Nutritional Considerations in Immunotoxicology (1984) (0)
Pediatrics: cardiology. (1979) (0)
Food production us patent 4738853 april 19 1988 (1988) (0)
The effects of n-6 polyunsaturated fatty acids on the expression of metastasis suppressors in cancer cells (1998) (0)
Nucleic acids and protein synthesis (1971) (0)
Schizophrenia associated with a genetic variant in cytosolic PLA2 (1996) (0)
Distribution of plasma phosphatidylcholine molecular species in rabbits fed fish oil is modulated by dietary n-6 fatty acids. (1995) (0)
Letter to the editor: etymology. (1968) (0)
Case reports in prostaglandins and medicine (1979) (0)
Necrobaeillosis in Man. (1944) (0)
Prostaglandin Deficiency and Endorphin Excess in Schizophrenia : The Case for Treatment with Penicillin , Zinc , and Evening Primrose Oil (2007) (0)
The alimentary tract (1973) (0)
n-6 Fatty acids and nervous system disorders (1998) (0)
Brain Lipids in Ageing and in Alzheimer's Disease: A Review (1994) (0)
The Common Animals (1971) (0)
Plasma Cholesterol Ester Fatty Acids: A New Biochemical Abnormality in Obstructive Jaundice (1995) (0)
Diabetes mellitus, compositions intended for the treatment of complications (1995) (0)
Composition for treatment of diabetic complications (1995) (0)
Book Review:Anthropometric Assessment of Nutritional Status. John H. Himes (1992) (0)
Alterations in plasma lipoprotein concentrations in patients with peripheral vascular disease. (1996) (0)
167 Arachidonic and docosahexaenoic acid levels in blood in schizophrenics who do and do not flush to oral niacin (1997) (0)
641 THERAPY OF CHRONIC NONSPECIFIC DIARRHEA OF CHILDHOOD: A PROSPECTIVE STUDY (1981) (0)
Hydralazine inhibits vascular reactivity by a mechanism independent of vascular prostaglandin biosynthesis: role of thromboxane synthetase in blocking hydralazine actions. (1986) (0)
Letter: Hepatorenal syndrome and prolactin. (1974) (0)
Derivatives of 1,3-propane diol-bioactive compounds. (1996) (0)
Actual versus self-reported intake and exercise in obesity. (1993) (0)
Vitamin D and the breast-fed baby. (1989) (0)
597 IRON (Fe) ABSORPTION IN THALASSEMIA MAJOR (THAL MAJ) AND THE EFFECTS OF TEA AS A CHELATING AGENT (1978) (0)
EFFECTS OF STARVATION IN INFANCY ON SUBSEQUENT LEARNING ABILITIES (1974) (0)
The Body Fluids and Blood (1973) (0)
Thromboxane A2 as a possible natural ligano for benzodiazephine receptors (1978) (0)
Letter: Prolactin and migraine. (1974) (0)
Body Compositional Changes in Response to Testosterone-Reply (1992) (0)
Food, pharmaceutical and cosmetic preparation, dilinoleoyl-mono-gamma-linolenyl-glycerol containing (1992) (0)
Proceedings: Action of lithium on the responses of the rat superior mesenteric vascular bed to noradrenaline and prolactin. (1975) (0)
The functioning of larger animals (1971) (0)
65-122 Cell membrane abnormalities In schizophrenia: Implications for treatment (1997) (0)
Effects of starvation in infancy (pyloric on subsequent learning abilities stenosis) (1975) (0)
Proceedings: Effects of prolactin on the responses of rat aortic wall strips to noradrenaline. (1974) (0)
Nutrition Discussion Forum (2003) (0)
Letter to the Editor (1984) (0)
Medical ideas by laymen (1975) (0)
The nervous system (1973) (0)
Scientists leaving science (1990) (0)
Warren Elwell Wheeler: May 10, 1909—Oct 22, 1976 (1976) (0)
Clinical forum. 5 - schizophrenia: the body in question. (1982) (0)
Tricyclic antidepressants, anxiety, thromboxane A2, and dipyridamole. (1979) (0)
Arterial-disease research. (1972) (0)
A method for containing the di-linoleoyl-mono-gamma-linolenyl-glycerol, pharmaceutically useful in the preparation of oil (1992) (0)
(Prog. Lipid Res., 25:633-635)A possible new mechanism of action of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs): Inhibition of essential fatty acid (EFA) metabolism (1986) (0)
Comment on potential errors in whole-body scintillation counting of 40K. (1984) (0)
Therapeutic and food-compositions that contain essential fatty acids and bioactive disulfide (1998) (0)
How accurate is the metabolic balance technique (1980) (0)
36: Alterations in plasma testosterone and sex hormone binding globulin during puberty (1976) (0)
Muscular Dystrophies and Thymic Deficiency (1983) (0)
Proceedings: Actions of cortisol, antidiuretic hormone and prolactin on fluid movements across the amniotic membrane of the guinea-pig. (1976) (0)
Plasma vanadium concentrations, lipoproteins and fatty acids in elderly people living near a smelter and in a control area (1992) (0)
Fatty Acid Composition of Regular Rat Chow and of the Evening Primrose Oil or Fish Body Oil Added to the Chow Fatty acid (2005) (0)
Pharmaceutical and dietary composition (1983) (0)
Ideas in biomedical science: reasons for the foundation of Medical Hypotheses. (1976) (0)
Metabolism of Li-_-Linolenate (LiGLA) in Human Prostate, Ovarian, and Pancreatic Carcinomas Grown in Nude Mice (1996) (0)
Production of phospholipase a2 inhibitor (1991) (0)
Disorders of Phospholipid Metabolism in Schizophrenia, Affective Disorders, and Neurodegenerative Disorders (2001) (0)
The Prevention of Experimental Nephrocalcinosis With Eicosapentaenoic Acid (Epa) And Evening Primrose oil (GLA) (1994) (0)
Tests of the Prolactin Secreting System (1973) (0)
Body composition and menarche: the Frisch hypothesis. (1980) (0)
The value of disturbance detectors (1970) (0)
Potatoes: A Reliable Source of Vitamin C Scorbutus Nauticus Cured without Citrus (1993) (0)
Conflict of interest (1989) (0)
Method for manufacturing a pharmaceutical composition for the treatment of osteoporosis and other bone diseases. (1987) (0)
Science and Religion (1969) (0)
Proceedings: Effects of treatment with ovine prolactin and bromocriptine upon growth and exchangeable calcium in mice. (1976) (0)
Effective clinical innovation. Author's reply (2002) (0)
Another lesson from the health care of European children. (1968) (0)
The Uncertainty Principle (1969) (0)
Calcium and the parathyroids (1971) (0)
[Prolactin, prostaglandins and medicine]. (1977) (0)
Summary Statement: Fatty Acids and Cancer (1994) (0)
Research and the medical student. (1961) (0)
Decrease in cerebral ventricular volume in end-stage Huntington's disease treated with purified eicosapentaenoic acid (2001) (0)
BACK TO BASICS (1996) (0)
Alexander Ashley Weech, MD (1977) (0)
LATE-ONSET NEPHROPATHIC CYSTINOSIS WITH MASSIVE PROTEINURIA. A STUDY OF THE RENAL LESIONS AND TUBULAR FUNCTIONS (1974) (0)
Response of plasma and liver cholesterol and fatty acids in hypercholesterolemic rats to short-term feeding of vegetable and fish oils (1987) (0)
Introduction — Hormones and Disease (1973) (0)
IN VITRO EFFECTS OF PHOSPHATIDYLCHOLINE ON DELTA 6-DESATURASE ACTIVITY ANDMEMBRANE FLUIDITY IN RAT LIVER MICROSOMES (1995) (0)
Implications for research (1970) (0)
Treatment by fatty acid (1995) (0)
Letter: Prolactin and migraine. (1974) (0)
Calculous disease ofthevermiform appendix (1966) (0)
(Nutr. Rep. Int., 36:021-027)Metabolism of marine n-3 fatty acids in diabetic and in cholesterol-fed essential fatty acid deficient rats: implication of delta-4-desaturase activity (1987) (0)
Book Review:Anthropometry: The Individual and the Population. S. J. Ulijaszek, C. G. N. Mascie-Taylor (1994) (0)
Kenya West of the Rift (1971) (0)
Unsaturated fatty ester and composition containing the same (1994) (0)
Proceedings: Renal interactions of prolactin and bromocriptine. (1976) (0)
RADIOACTIVITY IN THE ENVIRONMENT: SIGNIFICANT ISOTOPES IN FOODS. (1968) (0)
Ethics and editors. (1974) (0)
Proceedings: Prolactin as a stimulator of cardiac Beta-receptors. (1974) (0)
COMMITTEEON NUTRITION (1960) (0)
HAZARDS OF RADIOIODINE THERAPY (1966) (0)
100: Effect of estrogen on metabolic response to growth hormone (1976) (0)
Vincent A. Fulginiti, MD: Chief Editor (1983) (0)
A Genetic Abnormality in Schizophrenia Related To Phospholipase A2 (1996) (0)
(Nutr. Rep. Int., 36:1171-1183)Response of plasma and liver cholesterol and fatty acids of hypecholesterolemic rats to short-term feeding of vegetable and fish oils (1987) (0)
Composition for improving skin and its method (1989) (0)
SIGNIFICANT ISOTOPES IN FOODS (1968) (0)
Use of fatty acids to increase the intestinal absorption of calcium. (1993) (0)
Are methyl xanthines used as phosphodiesterase inhibitors also prostaglandin antagonists [proceedings]? (1977) (0)
Nutritional Requirements (2008) (0)
The effect of a high-sucrose diet on toxicological parameters in the lactating rat (1996) (0)
Effect of chloroquine on Epstein–Barr virus expression (reply) (1979) (0)
The effects of dietary protein and cholesterol on tissue cholesterol contents and N-6 fatty acid compositions in rats and mice fed a gamma-linolenate-rich diet. (1990) (0)
Proceedings: Effects of prolactin, antidiuretic hormone and aldosterone in the polyuric syndrome produced by lithium treatment in male rats. (1975) (0)
Responses of the whole body (1973) (0)
The radioactive "fall-out" problem. (1960) (0)
Should Milk Drinking by Children (2006) (0)
PLASTIC SPECIMEN-POUCH (1953) (0)
Six Thousand Manuscripts (1983) (0)
Unconventional publication. (1973) (0)
The structure of chemical substances (1971) (0)
Phospholipid metabolism and depression: new clinical trials (2002) (0)
RENIN AND HYPERTENSION (1966) (0)
93. Omega-3-fatty acids improve labelling efficiency, recovery and platelet survival: (1993) (0)
Treatment of male pattern baldness and undesirable hair growth (1988) (0)
The influence of the type of stress on the design of a control system (1970) (0)
Enriched or supplemented milk or milk derived product (1995) (0)
Diseases of the Adrenal Cortex (1973) (0)
Sodium, aldosterone and hypertension. (1971) (0)
Using ascorbyl gammalinolenate or ascorbyl-dihomo-gamma-linolenate to treat asthma, cancer, cardiovascular and anti-inflammatory. (1995) (0)
Ammonia intoxication: its relevance in total parenteral alimentation. (1973) (0)
Puerperal Lactation and Galactorrhea (1973) (0)
Progress in Drug Research (2002) (0)
Determination of Bromide Space using Anion-Exchange Chromatography for Measurement of Serum Bromide Concentration (1988) (0)
Letter to the editor: recommended dietary allowances. (1969) (0)
Plasma fatty acids and smoking in cases of peripheral arterial disease and controls. The Edinburgh artery study (1993) (0)
LITHIUM GAMOLENATE INHIBITS HIV REPLICATION IN CHRONICALLY INFECTED H9 CELLS AND ACUTELY INFECTED PBMC (1994) (0)
The Modern Peoples (1971) (0)
The actions of bumetanide on the response of rat arterioles to noradrenaline and prolactin. (1975) (0)
2209 – ULTRA-VIOLET RADIATION INHIBITS THROMBOXANE A2 SYNTHESIS (1978) (0)
Non-steroidal anti-inflammatory drug, production thereof and medicine containing the same (1995) (0)
Points: Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon (1986) (0)
Abnormal involuntary movements (AIMS) and red cell lipids (1995) (0)
Control of Prolactin Secretion (1973) (0)
(Ann. Nutr. Metab., 30:081-086)Influence of different dietary fatty acid sources on erythrocyte lipids and plasma and liver essential fatty acids in hamster fed ethanol (1986) (0)
Traitement a l'acide gras (1993) (0)
A cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia who have seriously and dangerously violently offended (2003) (0)
(Lipids, 24:565-571)Effect of essential fatty acid depletion on tissue phospholipid fatty acid composition in spontaneously hypertensive and normotensive rats (1989) (0)
Abnormalities ofessential fatty aciddistribution intheplasma phospholipids ofpatients withbladder cancer (1991) (0)
"Essential Physics, Chemistry and Biology" (1971) (0)
Myocardial Infarction and Thrombo-Embolic Diseases (1973) (0)
BIPHASIC DISTRIBUTION OF MEMBRANE FATTY ACIDS IN SCHIZOPHRENICS WITH POSITIVE AND NEGATIVE SYMPTOMS (1992) (0)
Jobs gloom: a military solution? (1979) (0)
Calcium Metabolism and the Bone (1969) (0)
(Prostaglandins, Leukotrienes Med., 26:253-263)The influence of dietary supplementation of marine oil and evening primrose oil on prostaglandin production by the rat mesenteric vasculature (1987) (0)
The ras oncogene alters fatty acid metabolism in related cell lines (1990) (0)
Peroxisome-proliferator activated receptors (PPAR): Possible involvement in schizophrenia (2003) (0)
Comments and correspondence in prostaglandins and medicine (1979) (0)
Prevention of artery reocclusion (1992) (0)
Proceedings: Effects of bromocriptine and prolactin on thymus growth and thymus uptake of tritiated thymidine in mice of the Swiss and Bar Harbor 129 strains. (1975) (0)
Essential physics, chemistry and biology : a guide to important principles for nurses and allied professions (1971) (0)
Endocrine and Genetic Diseases of Childhood. (1969) (0)
551 LEAN WEIGHT AS A FUNCTION OF BODY FAT (1981) (0)
Essential fatty acids regulate the expression of tumour suppressor genes in cancer cells (1998) (0)
Fatty acid derivative and preparation containing the same (1995) (0)
The Maintenance of a Constant Internal Environment (1973) (0)
Diagnosis and management of severe infections in infants and children; a review of experiences since the introduction of sulfonamide therapy; staphylococcal empyema; the importance of pyopneumothorax as a complication. (1946) (0)
Examination of the effect of route of administration and dose on the diabetogenic effects of streptozotocin (1994) (0)
Units, decimals and graphs (1971) (0)
In vitro evaluation of combinative drugs at subthreshold concentrations : a novel approach to antimicrobial and antitumor therapy (1991) (0)
Membranes and Psychiatric Disorders (1996) (0)
Dyskinesia and pulmonary function—A study of men born in 1933 (1998) (0)
88-3 Archidonic and docosahexaenoic acid levels in blood in schizophrenics who do and do not flush to oral niacin (1997) (0)
Proceedings: Effects of prolactin and bromocriptine on the response to Moloney sarcoma virus in mice. (1975) (0)
APOPLEXY of youth. (1957) (0)
The human organism : an introduction to physiology (1966) (0)
Ideal Treatment For Hemorrhoids (1962) (0)
Therapeutic treatment with fatty acid (1992) (0)
CRITICAL CLOSING PRESSURE (1967) (0)
Bird Life and Where to Find It (1971) (0)
Lean body mass on low calorie diets. (1986) (0)
DIAZEPAM AND CANCER (1982) (0)
In Reply: Hazards of Radioactive Fallout (1962) (0)
Enriched fruit juice (1995) (0)
(Pharmacol. Biochem. Behavior, 26:1285-1292)Dietary manipulation of ethanol preference in the Syrian golden hamster (1986) (0)

This paper list is powered by the following services:

Other Resources About David Horrobin

en.wikipedia.org

What Schools Are Affiliated With David Horrobin?

David Horrobin is affiliated with the following schools:

David Horrobin's Academic­Influence.com Rankings

David Horrobin's Degrees

Why Is David Horrobin Influential?

David Horrobin's Published Works

Published Works

Other Resources About David Horrobin

What Schools Are Affiliated With David Horrobin?

David Horrobin's AcademicInfluence.com Rankings